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i. Resumo 
O reino das plantas tem disponibilizado vários agentes terapêuticos para o tratamento de 
um grande número de doenças. Parte do seu interesse advém do conhecimento que tem 
sido adquirido ao longo dos séculos, o que justifica o seu uso na medicina tradicional. 
Embora o cancro seja uma doença pouco descrita na medicina tradicional, as plantas têm 
contribuído largamente para o arsenal terapêutico atual daquela doença. No entanto, o 
mesmo não poderá ser dito dos agentes antimicrobianos, uma vez que derivam 
habitualmente de metabolitos secundários produzidos por bactérias e fungos saprófitos e 
não diretamente pelas plantas. 
As plantas do género Cecropia têm sido utilizadas na medicina tradicional, especialmente 
em países da América Latina, o que explica o grande número de estudos relativos à sua 
atividade biológica. No entanto, são poucos os estudos dedicados aos seus efeitos 
anticancerígenos e antimicrobianos. De facto, a espécie Cecropia catarinensis nunca foi 
investigada nestas áreas de pesquisa. 
Este trabalho relata o estudo fitoquímico das folhas da Cecropia catarinensis, que inclui a 
avaliação in vitro dos efeitos inibidores do crescimento de células do adenocarcinoma da 
mama (MCF-7), de células do cancro do pulmão (NCI-H460) e de células do melanoma 
(A375-C5) pelo extrato bruto metanólico da planta (CME) e por duas frações 
semipurificadas (CME1 e CME2), utilizando-se o ensaio de SRB; e a avaliação da 
atividade antimicrobiana do extrato e das frações da planta (CME, CME1 e CME2) e dos 
compostos isolados a partir de CME1 sobre as bactérias Staphylococcus aureus ATCC 
25923, uma estirpe clínica de Staphylococcus aureus resistente à meticilina, Escherichia 
coli ATCC 25922 e Pseudomonas aeruginosa ATCC 27853, bem como sobre os fungos 
Cândida albicans ATCC 10231, Aspergillus fumigatus ATCC 46645 e uma estirpe clínica 
de Trichophyton rubrum, utilizando o método de microdiluição em caldo. 
O extrato bruto metanólico inibiu o crescimento das três linhas celulares utilizadas neste 
ensaio. A fração CME1 apresentou a maior atividade inibitória de entre as três amostras 
testadas. A fração CME2 apresentou uma atividade moderada sobre as células MCF-7 e 
NCI-H460 e foi inativa para as células A375-C5. A fração CME1 foi escolhida para ser 
purificada, fornecendo quatro compostos. Foram propostas as estruturas de dois 
triterpenóides pentacíclicos, o ácido ursólico e o uvaol, e de dois esteróides, a β-
sitostenona e o β-sitosterol. O composto proposto como sendo ácido ursólico demonstrou 
ser seletivo sobre as bactérias gram-positivas.  
Palavras-chave: Cecropia catarinensis, metabólitos secundários, triterpenóides 
pentacíclicos, atividade antitumoral, atividade antimicrobiana. 
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ii. Abstract 
Plants have a long history of affording therapeutic agents for the treatment of a large 
number of diseases. Part of their interest comes from the knowledge that has being 
acquired over the centuries, which justifies their use in traditional medicine. Although 
cancer is a poorly described disease in traditional medicine, plants have widely 
contributed to the current therapeutic arsenal of that disease. However, the same cannot 
be said about antimicrobial agents as they have usually derived from secondary 
metabolites that are produced by soil bacteria and fungi and not directly by plants. 
Plants of the genus Cecropia have been used in traditional medicine, especially in Latin 
American countries, which explains the large number of studies concerning their biological 
activity. However, there are few studies dedicated to their anticancer and antimicrobial 
effects. Indeed, the specie Cecropia catarinensis was never investigated concerning this 
area of research. 
This work reports the phytochemical study of the leaves of Cecropia catarinensis, which 
includes the in vitro evaluation of the growth inhibitory effects of the methanolic crude 
extract CME and two semi purified fractions (CME1 and CME2) towards human breast 
adenocarcinoma cells (MCF-7), human non-small cell lung cancer cells (NCI-H460) and 
human melanoma cells (A375-C5), using the SRB assay; and the antimicrobial activity 
evaluation of the crude extracts (CME, CME1 and CME2) and the compounds isolated 
from CME1 against the bacteria Staphylococcus aureus ATCC 25923, a clinical strain of 
MRSA, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853, and 
the fungi Candida albicans ATCC 10231, Aspergillus fumigatus ATCC 46645 and a 
clinical strain of Trichophyton rubrum, using the broth microdilution method. 
The crude methanolic extract inhibited the growth of the three human tumour cell lines 
used in this biological assay. CME1 was not only active against the panel of cancer cells 
but presented the highest inhibitory activity among the three tested samples. CME2 
showed moderate activity against MCF-7 and NCI-H460 cells and was inactive towards 
A375-C5 cells. CME1 was chosen to be further purified, which afforded four compounds. 
It was proposed the structures of two pentacyclic triterpenoids, uvaol and ursolic acid, and 
two steroids, β-sitostenone and β-sitosterol. The compound proposed as ursolic acid 
demonstrated to be selective against gram-positive bacteria.  
Keywords: Cecropia catarinensis, secondary metabolites, pentacyclic triterpenoids, 
antitumor activity, antimicrobial activity. 
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Catharanthus roseus: http://www.biolib.cz/en/taxonimage/id54089/;  
Taxus brevifolia: http://www.dereilanatureinn.ca/woodlands/berry-patch/; 
Camptotheca acuminata: http://www.chinahorticulture.net/wp/en/2013/02/16/camptotheca-acuminata/; 
Podophyllum peltatum: http://www.missouribotanicalgarden.org/gardens-gardening/your-garden/plant-
finder/plant-details/kc/l800/podophyllum-peltatum.aspx. 
Catharanthus roseus Taxus brevifolia 
Camptotheca acuminata Podophyllum peltatum 
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1. Introduction 
Since ancient times, humans have been using nature as a source of therapeutic agents 
and plants have particularly sustained all sophisticated traditional medicine systems, such 
as the Egyptian medicine (documented in "Ebers Papyrus"), the traditional Chinese 
medicine (with the Chinese Materia Medica) or the Indian Ayurvedic system. On the 
Western side of the world, both Greeks and Romans developed the rational use of herbal 
drugs and the Arabs preserved the Greco-Roman expertise and included the use of their 
own sources, together with Indian and Chinese herbs that were unknown to the Romans 
and Greeks [Cragg and Newman, 2013; Ji et al., 2009].  
Indeed, approximately 65% of the world population predominately relied on plant 
traditional medicines for primary healthcare. Moreover, plants have an indirect role in the 
healthcare systems, since plants have been affording lead compounds for the 
development of drugs that are now in clinical practice. For example, galegine (1) was 
originally isolated from Galena officinalis L. and was used as a model for the synthesis of 
the oral antidiabetic agent metformin (2); or papaverine (3) that was obtained from 
Papaver somniferum and that led to verapamil (4), a calcium channel blocker used to 
treat hypertension; or otherwise, the same plant Papaver somniferum that afforded the 
painkillers morphine and codeine; or even the antimalarial quinine (5) that constituted the 
basis for the synthesis of other antimalarial agents chloroquine (6) and mefloquine (7) 
and that was originally isolated from the bark of Cinchona species, which had been used 
by Amazonian indigenous groups for the treatment of fevers [Cragg and Newman, 2013]. 
 
Figure 1 – Strutures of galegine (1), metformin (2), papaverine (3), verapamil (4), quinine (5), 
chloroquine (6) and mefloquine (7) 
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Although cancer had been a poorly described disease in folk or traditional medicine, 
plants have a long history of affording anticancer agents to the current therapeutic 
arsenal. Between them, Vinca alkaloids are some of the best well-known plant-derived 
anticancer drugs [Cragg and Newman, 2013]. Vincristine (8) and vinblastine (9) are 
naturally occurring Vinca alkaloids, isolated from the periwinkle plant Catharanthus 
roseus, formerly known as Vinca rosea. The Vinca alkaloids bind specifically to the β 
subunit of tubulin dimmers at the so-called “Vinca domain”, inducing a conformational 
change in tubulin which leads to the formation of paracrystalline aggregates. The pool of 
available free tubulin dimmers is decreased, which shifts the equilibrium and leads to 
microtubule depolymerisation and mitotic spindle destruction. Therefore, the actively 
dividing cells are inhibited to progress through mitosis, which results in metaphase arrest 
that then triggers apoptosis [Ng, 2011; Nobili et al., 2009]. 
  
Figure 2 – Strutures of vincristine (8), vinblastine (9), vindesine (10), vinorelbine (11) and 
vinflunine (12)  
Vindesine (10) and vinorelbine (11) are semisynthetic analogues that were obtained 
from structural modifications of vinblastine. Those derivatives interact more weakly with 
tubulin that the naturally occurring Vinca alkaloids, affecting the microtubule dynamics in a 
different way [Nobili et al., 2009]. Moreover, the recently approved vinflunine (12) is a 
fluorinated analogue of vinorelbine that has the lowest overall in vitro affinity to tubulin 
among the Vinca alkaloids family, being such interaction the most readily reversible. 
However, this weaker interaction does not correlate to a lower efficacy because vinflunine 
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has shown to be the most active against a number of murine and human tumour 
xenografts. The exact mechanism is not fully understood but, apart from the microtubule 
disturbance effects, vinflunine seems to inhibit the vascular endothelial cell growth, 
possessing antiangiogenic activity [Ng, 2011]. 
The natural terpene paclitaxel (13) is the most interesting plant-derived anticancer drug 
discovered in recent years [Cragg and Newman, 2013]. The compound is a microtubule-
stabilizing agent that was isolated from the bark of the Pacific yew Taxus brevifolia and is 
widely used to treat breast, ovarian and lung carcinomas [Nobili et al., 2009]. Several 
supply problems were overcome by its semisynthesis from 10-deacetylbaccatin III that is 
extracted from the twigs and needles of the European yew Taxus baccata. Docetaxel (14) 
is also obtained from 10-deacetylbaccatin III by semisynthesis [Nicolaou et al., 2009; 
Nobili et al., 2009]. Both drugs arrest cell cycle at G2/M stage by binding to specific 
sequences of the β-tubulin subunit, the so-called “taxane binding site”, which ultimately 
leads to apoptosis [Nobili et al., 2009].  
       
Figure 3 – Strutures of paclitaxel (13) and docetaxel (14) 
Another example of the role of plants in the anticancer drug discovery is the 
camptothecins family. Actually, the enzyme topoisomerase I was identified as a target for 
cancer chemotherapy by camptothecin, which was isolated from the Chinese ornamental 
tree Camptotheca acuminata. However, severe bladder toxicity prevented camptothecin to 
become clinically approved. Less toxic semisynthetic analogues, such as irinotecan (15) 
and topotecan (16), were approved for the treatment of colorectal and ovarian cancer 
respectively [Cragg and Newman, 2013; Nobili et al., 2009]. Camptothecins derivatives 
share a common five-ring structure with a chiral centre located in the terminal lactone, 
where its S-conformation and hydroxyl group are essential for biological activity. As 
topoisomerase I bind covalently to the DNA double-strand by a reversible trans-
esterification reaction, camptothecins stabilize this covalent DNA-topoisomerase I 
complex, preventing relegation during the catalytic cycle [Nobili et al., 2009].   
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Figure 4 – Strutures of irinotecan (15) and topotecan (16) 
Root extracts of the Indian plant Podophyllum peltatum have been used as folk medicines 
for centuries. Etoposide (17) and teniposide (18) are semisynthetic derivatives of 4-
epipodophyllotoxin and are cell cycle dependent and phase specific, affecting the S and 
G2 phases of cell division. Being topoisomerase II poisons, these drugs form a stable 
drug-DNA-topoisomerase II ternary complex which prevents the releasing from the DNA 
and results in DNA double strand-breaks [Nobili et al., 2009]. 
      
Figure 5 – Strutures of etoposide (17) and teniposide (18) 
Unlike the successful plant-derived antitumor agents, almost all antibacterial agents 
derived from secondary metabolites that were produced by soil bacteria and fungi and not 
directly by plants. However, there has been an enormous effort to exploit the plant 
kingdom in the past, without a notable success to date. Curiously, the use of traditional 
plant-based medicines is common in some countries, but the intrinsic value of plant 
extracts as therapeutic concoctions does not follow the modern perceptions of efficacy 
and safety that could be determined by controlled clinical trials. Indeed, plant extracts may 
disadvantageously interact with modern medicines and may be harmful to users [Taylor, 
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2013]. However, this not means that plants extracts may not be considered as a starting 
point for the purification of bioactive chemical constituents for the development of 
antibiotic agents.  
Nonetheless, the in vitro antibacterial activity of plant crude extracts, which is usually 
determined by the minimum inhibitory concentration (MIC), is generally high in a 
considerable number of studies that have used unfractionated extracts of roots and aerial 
parts of plants. However, there are an extensive number of plant-derived compounds with 
antimicrobial activity, such as aromatic secondary metabolites that are responsible for 
plant defence and constitute plant pigments and odours, or alkaloids that have long been 
known to possess antiparasitic activity, or plant-derived coumarins that have shown good 
activities against Gram-positive bacteria due to be inhibitors of bacterial DNA gyrase, or 
flavonoids and isoflavonoids that display weak antibacterial activity because they 
intercalate into biomembranes and favourably destabilize and modify the membrane 
properties of some Gram-positive pathogens, or even some terpenoids and isoprene-
based constituents of essential oils that have good-to-moderate activities against Gram-
positive bacteria. A final amazing example is the plant Berberis fremontii that synthesises 
the alkaloid berberine (a bacterial DNA intercalator) and also synthesises the compound 
5’-methoxyhydnocarpin (an inhibitor of multidrug resistance pump), preventing extrusion 
of berberine from bacterial cytoplasm. Indeed, there are plant-derived products that could 
have a potential value to modify complex bacterial phenotypes and the paradigms of 
virulence and bacterial resistance [Taylor, 2013]. 
The objective of this work was to proceed to the chemical and biological studies of the 
leaves of Cecropia catarinensis, which included: the isolation, purification and elucidation 
of secondary metabolites from the plant crude extracts; the biological evaluation of the 
crude extracts and the isolated compounds for the antimicrobial activity against the 
bacteria Staphylococcus aureus ATCC 25923, a clinical strain of MRSA, Escherichia coli 
ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 and the fungi Candida 
albicans ATCC 10231, Aspergillus fumigatus ATCC 46645 and a clinical strain of 
Trichophyton rubrum, using the broth microdilution method; the biological evaluation of the 
plant extracts and the isolated secondary metabolites for the in vitro growth inhibitory 
activity towards a panel of human tumour cell lines (MCF-7, NCI-H460 and A375-C5 cells) 
using the SRB assay. 
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Chapter 2 
The genus Cecropia as a potential source of 
therapeutic agents 
 
 
 
 
 
 
  
  
  
   
 
 
 
 
 
 
Cecropia glaziovii: http://sites.google.com/site/biodiversidadecatarinense/plantae/magnoliophyta/urticaceae/ 
cecropia-glaziovii-embauba; 
Cecropia hololeuca: http://orienteocidente.wordpress.com/2013/07/20/embauba-branca-cecropia-hololeuca-3/; 
Cecropia obtusifolia: http://wildlifeofhawaii.com/flowers/416/cecropia-obtusifolia-trumpet-tree/; 
Cecropia pachystachya: http://www.natureloveyou.sg/Cecropia%20pachystachya/Main.html. 
Cecropia glaziovii Cecropia hololeuca 
 
Cecropia obtusifolia Cecropia pachystachya 
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2. The genus Cecropia as a potential source of therapeutic agents 
The genus Cecropia is constituted approximately by 60 species that were originally 
included in the family Moraceae and that were lately reclassified and included in the new 
family Cecropiaceae. However, recent taxonomic studies based on morphological and 
phylogenic approaches included the genus Cecropia in the family Urticaceae. These 
plants exist in the tropical and subtropical regions of the South and Central America 
[Costa et al., 2011].  
Species of the genus Cecropia have been used in folk medicine for the treatment of the 
most common chronic diseases such as Diabetes Mellitus, hypertension or asthma. 
Indeed, their extracts are included in Pharmacopoeias of various South American 
countries which demonstrate their use as phytomedicines. For this reason, there are 
several biological studies with standardized extracts of these plants for the evaluation of 
their hypoglycaemic or hypotensive properties, among others, which also included an 
attempt to understand their mechanisms of action. However, there are few reports on the 
isolation and on the chemical characterisation of the secondary metabolites present in 
their extracts, as well as, on the biological evaluation of their antifungal, antibacterial or 
cytotoxic activities.  
The next sections correspond to a brief literature review of the chemical and the biological 
profiles of some species of the genus Cecropia. Our plant Cecropia catarinensis will be 
considered as individual specie as it was classified by Professor Jorge Pedro Carauta. 
Indeed, there are disagreements in the classification of C. catarinensis plants that occur in 
the South of Brazil, since these plants have been considered as C. pachystachya by some 
authors [Costa et al., 2011], who in some extent support the idea that C. catarinensis is no 
more than a synonymous of C. pachystachya. They argued that the chemical fingerprint of 
extracts belonging to plants collected in the South and the Midwest of Brazil were 
compared by TLC and by HPLC, showing that there were no qualitative differences 
between samples. They also claimed that there are taxonomic studies that indicate that 
the plants belong to the same species but they did not detail the nature of those studies. 
Phylogenetic studies would be necessary to support the findings on the chemical 
fingerprints of the samples examined.  
2.1. Cecropia glaziovii 
The plant Cecropia glaziovii Sneth is a characteristic tree of the South-eastern Brazilian 
coasts that have been used in folk medicine as a cardiotonic, antihypertensive and 
antiasthmatic remedy [Rocha et al., 2002]. In fact, in several ethnopharmacological 
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reports, C. glaziovii has been described for the control of high-blood pressure and as a 
diuretic [Costa et al., 2011]. 
These ethnopharmacological features should be based on the chemical composition of 
the plant. Firstly, a chemical investigation of a standardized aqueous extract of the dried 
leaves of C. glaziovii revealed the presence of chlorogenic acid (19), catechins [(+)-
catechin (20) and (-)-epicatechin (21)], procyanidins {procyanidin B2 [epicatechin-
(4β→8)-epicatechin] (22), procyanidin B3 [catechin-(4α→8)-ent-catechin]  (23), 
procyanidin B5 [epicatechin-(4β→6)-epicatechin]  (24) and procyanidin C1 
[epicatechin-(4β→8)-epicatechin-(4β→8)-epicatechin]  (25)} and flavonoids 
[isoorientin (26) and isovitexin (27)] by HPLC analysis. The aqueous extract was 
partitioned with n-butanol and the resulting butanolic fraction was further purified by 
preparative HPLC columns, yielding 1.5% of chlorogenic acid, 12.6% of catechins, 22% of 
procyanidins and 23% of flavonoids. These substances were chemically identified by 13C-
NMR, 1H-NMR and LC-MS and their structures are represented in the figure 6 [Tanae et 
al., 2007].  
 
Figure 6 – Structures of chlorogenic acid (19), (+)-catechin (20), (-)-epicatechin (21), 
procyanidin B2 (22), procyanidin B3 (23), procyanidin B5 (24), procyanidin C1 (25), 
isoorientin (26) and isovitexin (27)  
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Secondly, it is also important to mention an experimental design of a method that 
evaluated the contents of chlorogenic acid and caffeic acid (28) extracted from C. 
glaziovii Sneth. The detection of caffeic acid in this specie was firstly reported in this 
paper. The HPLC-DAD method was validated and enabled the separation and 
quantification of the two phenolic acids [Arend et al., 2011]. 
However, before these two studies, the flavonoids orientin (29) and the O-heteroside 
isoquercetrin (30) were also reported for C. glaziovii [Costa et al., 2011]. 
 
Figure 7 – Structures of caffeic acid (28), orientin (29) and isoquercetrin (30)  
The already described standardized aqueous extract and its purified fractions were tested 
for its biological activity in vivo on vital physiological systems such as the cardiovascular, 
the respiratory, the gastrointestinal and the central nervous system (CNS), and were 
reported by different members of the same group of researchers [Tanae et al., 2007]. 
Therefore, the antihypertensive activities of the aqueous extract and the butanolic fraction 
were compared on normotensive rats and on some validated experimental models of 
hypertensive rats in order to understand the hypotensive mechanism of action. The results 
indicated that the treatment of normotensive rats induced blood pressure reduction after 
repeated oral administration and this effect was probably produced by low polarity 
compounds as the hypotensive activity was more pronounced with the butanolic fraction. 
Furthermore, both extracts decreased the blood pressure of hypertensive rats and this 
study indicated that the plant extracts did not seem to interfere with the renin-angiotensin-
system (RAS). Additionally, when hypertension of normotensive rats was induced by the 
prior administration of an inhibitor of nitric oxidase synthase, the subsequent oral 
administration of the aqueous extract caused a significant and persistent reduction in 
blood pressure, suggesting that the hypotensive effect may not be related to nitric oxide 
synthesis. The hypotensive mechanism of C. glaziovii might be related to specific 
blockade of calcium channels on smooth muscles [Lima-Landman et al., 2007].  
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In a parallel study, the angiotensin I converting enzyme (ACE) activity of the standardized 
aqueous extract was evaluated in rats, in a comparative study with captopril. The known 
ACE inhibitor was used as a positive control on the same rats, which were also treated 
with a single dose of the aqueous extract and with repeated doses for 60 days. The 
plasma ACE activity during acute or prolonged treatment did not changed and was not 
correlated with the simultaneously recorded hypotension, unlike when rats were treated 
with captopril [Ninahuaman et al., 2007]. 
Those antihypertensive properties that were found in vivo contrasted with the results 
obtained for other researchers who described the in vitro reduction of ACE activity by the 
dichloromethane/methanol (1:1) extract of C. glaziovii [Costa et al., 2011; Ninahuaman et 
al., 2007]. 
Even before those two aforementioned studies reported by Lima-Landman et al. and 
Ninahuaman et al., the cardiovascular interest of the plant has been scientifically 
investigated for some time and it has been observed that animals were much calmer in 
the experiments when they were chronically treated with C. glaziovii extracts. These 
observations prompted the group to investigate the effects of C. glaziovii in the Central 
Nervous System (CNS). In a period prior to the chemical standardization of the aqueous 
extract, the group analysed the anxiolytic-like effect of the aqueous extract and two semi-
purified fractions obtained from the leaves of C. glaziovii in mice. The behavioural data 
showed that the effects were not evident after a single-dose treatment but were 
significantly observed after the repeated treatment. They also found that the anxiolytic-like 
effects were 5 to 10 times greater in the semi-purified fractions [Rocha et al., 2002].  
The last investigation guided the group for the future biological evaluation, the 
antidepressant activity of C. glaziovii, because a dual anxiolytic and antidepressant-like 
activity is generally described for medicines. The standardized aqueous extract and the 
purified fraction were evaluated on in vivo forced swimming test in rats and the increased 
animal mobility indicated an antidepressant-like effect. This effect might be correlated with 
the hypotensive activity of the plant. However, in the ex vivo evaluation of hippocampal 
monoamines levels test, the neurotransmitters biochemical analysis of rats treated with 
the butanolic fraction demonstrated a significant increase in monoamines levels. 
Additionally, the study also aimed to search for the active compounds presented in plant 
extracts and their underlying mechanism of action by in vitro tests using synaptosome 
preparations of different brain regions necessary for the evaluation of the monoaminergic 
uptake. Among the isolated catechins and procyanidins, the results showed that 
procyanidin B3, catechin and procyanidin B2 significantly inhibited the monoamines 
uptake in brain synaptosomes. However, flavonoids did not blockade the monoamines 
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uptake. These results suggest that catechins and procyanidins may contribute to the 
antidepressant-like effect of C. glaziovii by blocking the monoamine reuptake, but 
pharmacokinetic studies are still needed to establish the correlation of these in vitro 
results and the in vivo antidepressant-like activity of C. glaziovii extracts [Rocha et al., 
2007]. 
As already referred, these researchers also evaluated the effects of the standardized 
aqueous extract and the butanolic purified fraction on the respiratory system, using 
unrestrained guinea pigs challenged with histamine by recording the changes in the 
respiratory pressure and rate. Although the plant extract effectively inhibited the 
histamine-induced broncospasm, this effect was mild when compared to the protection 
provided by ketotifen, a known H1-histamine receptor antagonist. Furthermore, the in vitro 
assays with guinea pig tracheal preparations showed that the plant extract was non-
competitive toward histamine. Therefore, the C. glaziovii broncospasm protection seemed 
to be related to other mechanism. In order to find that mechanism, the group pre-treated 
animals with propanolol, which resulted in the inhibition of the tracheal relaxation induced 
by the butanolic fraction. This β-adrenergic agonist effect was also observed in vitro at 
high concentration of the purified fractions due to have induced the relaxation of the 
cholinergic tonus in guinea pig tracheal preparations [Delarcina et al., 2007]. 
The last study with the standardized aqueous extract and the butanolic fraction of C. 
glaziovii corresponded to the assay on gastric acid secretion of pylorus-ligated mice and 
on acute models of gastric mucosal lesions. The results demonstrated that the 
intraduodenal injection of the aqueous extract decreased the volume and the total acidity 
of gastric secretion but without changing its pH. In turn, the butanolic extract not only 
reduced the volume and total acidity of the gastric secretion, but also its pH because the 
organic fraction was more concentrated than the aqueous extract in active compounds. 
Furthermore, the assays with the acute models of gastric mucosal lesions demonstrated 
the antiulcer activity of the butanolic fraction, since pre-treatment of animals with the 
butanolic fraction protected against gastric ulcers induced by stress, ethanol and 
indomethacin. Additionally, the group performed an in vitro assay with rabbit gastric H+, 
K+-ATPase preparations in order to verify the inhibitory effect of the butanolic fraction and 
the isolated compounds.  The butanolic fraction inhibited the gastric proton pump as well 
as all the isolated compounds with IC50 values similar to the obtained with the butanolic 
fraction. Therefore, the antacid and antiulcer effects of C. glaziovii may be related to the 
inhibition of the gastric proton pump by the polyphenolic active constituents [Souccar et 
al., 2008]. 
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Lastly, the in vitro antiviral activity of Cecropia glaziovii Sneth was investigated using the 
crude extract obtained from the leaves of the plant and their related fractions, a butanolic 
fraction and a C-glycosylflavonoid-enriched fraction (confirmed by HPLC-DAD). These 
samples were tested on human herpes virus types 1 and 2 (HHV-1, HHV-2) replication 
and all the samples were active but the C-glycosylflavonoid-enriched fraction was the 
most active. For this reason, the group decided to evaluate the viral multiplication steps 
with the C-glycosylflavonoid-enriched fraction and then to elucidate the mechanism of 
action. The results seemed to indicate that the C-glycosylflavonoid-enriched fraction only 
reduced the viral infectivity of HHV-2. However, the fraction inhibited the entry into cells, 
inhibited the viral cell-to-cell spread and impaired envelope proteins of both viruses, as the 
envelope plays important rules in viral attachment and penetration. Furthermore, the 
group tested isovitexin and isoorientin separately and found that these compounds were 
both inactive against HHV-1 and HHV-2 replication, which suggested that the C-
glycosylflavonoid-enriched fraction has synergistic effects that need to be studied in more 
detail [Silva et al., 2010]. 
2.2. Cecropia hololeuca 
According to Costa et al., the plant Cecropia hololeuca Miquel was listed in the first edition 
of the Brazilian Pharmacopeia [Costa et al., 2011] and Botsaris referred in his research 
article that the antimalarial proprieties of C. hololeuca were considered for the first time in 
ethnobotanical studies. Indeed, the general indications found in ethomedicinal studies 
were diuretic, antihypertensive, sedative, anti-inflammatory, expectorant or antiasthmatic, 
among others, being lately indicated as an adjuvant in the treatment of malaria that was 
characterised by very high fever or neurological symptoms. However, no scientific data on 
antimalarial activity was referred [Botsaris, 2007].  
The C-glycosylflavonoids (orientin and isoorientin) and the proanthocyanidins (catechin, 
epicatechin, procyanidin B2 and procyanidin C1) were identified in C. hololeuca as these 
chemical groups have been described as the main constituents of the plant. Additionally, 
other phenolic compounds were also described, namely chlorogenic acid and 
protocatechuic acid (31) [Costa et al., 2011].  
 
Figure 8 – Structure of protocatechuic acid (31)  
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In an in vitro biological study, the ethanolic extract obtained from the leaves and barks of 
C. hololeuca was examined for its ACE inhibition, showing that the extract inhibited the 
ACE action at 0.33 mg/mL. This activity may result by a possible synergism of the 
compounds that constituted the extract, as C-glycosylflavonoids and proanthocyanidins 
were inactive when tested separately [Costa et al., 2011].   
2.3. Cecropia lyratiloba 
The plant Cecropia lyratiloba Miquel afforded a new apigeninglycoside [apigenin 6-C-
galactosyl-6’’-O-β-galactopyranoside (32)], isoorientin and a mixture of orientin and 
isovitexin. The plant leaves were extracted with methanol and the crude extract was then 
partitioned with ethyl acetate in order to obtain a fraction rich in flavonoids. This fraction 
was then submitted to a countercurrent chromatography which demonstrated to be an 
effective method to resolve the flavonoid enriched fraction, enabling the isolation of the 
aforementioned C-glycosylflavonoids [Oliveira et al., 2003]. 
 
Figure 9 – Structure of apigenin 6-C-galactosyl-6’’-O-β-galactopyranoside (32) 
In another study, the methanolic extract obtained from the dried leaves of C. lyratiloba 
was treated with different solvents and then chromatographed on a silica gel column, 
yielding three fractions (a terpenoid, a flavonoid and a tannin fraction). The flavonoid 
fraction was treated twice by HSCCC, resulting in the separation of isoorientin and a 
mixture of orientin and isovitexin. The effects in vitro of the methanolic extract and the 
flavonoid fraction were afterwards investigated on the contractibility of cardiac, vascular 
and tracheal smooth muscles from rats. Unlike the flavonoid fraction that reduced the 
isometric tension of the electrically stimulated papillary muscles, the methanolic extract 
did not affect the amplitude of contraction of these muscles, suggesting that only the 
flavonoid fraction may alter the cardiac contractibility. In turn, the effects on the vascular 
muscles were investigated in the aorta and both samples produced vascular smooth 
muscle relaxation in a dose-dependent manner and with the same magnitude. The role of 
the endothelium in the vascular contractibility was also evaluated and the group founded 
that vasodilatation was dependent on functional endothelium. Additionally, the mechanism 
of vasodilatation was investigated and the effect might be mediated by the release of nitric 
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oxide by the endothelium as the aortic rings were pre-incubated with a nitric oxide 
inhibitor. Regarding the tracheal smooth muscle, the samples had no effect in the 
contractile response. Finally, the isolated flavonoids were also tested on the vascular 
smooth muscle for the attempt to identify the active compounds. Isoorientin and the 
mixture of orientin and isovitexin produced lower effects than the flavonoid fraction, which 
may suggest a synergism in the flavonoid fraction. The group concluded that 
vasodilatation may contribute to the antihypertensive effect of C. lyratiloba [Almeida et al., 
2006].  
Rocha et al. reported the isolation and the cytotoxic evaluation of four pentacyclic 
triterpenoids. Therefore, euscaphic acid (33), tormentic acid (34), 2-α-acetyl tormentic 
acid (35) and 3-β-acetyl tormentic acid (36) were isolated from the barks of C. lyratiloba 
using HSCCC and the chemical characterisation of the compounds was determined GC-
MS, 1H and 13C NMR [Rocha et al., 2007].  
 
Figure 10 – Structures of euscaphic acid (33), tormentic acid (34), 2-α-acetyl tormentic acid 
(35) and 3-β-acetyl tormentic acid (36) 
The cytotoxicity of those isolated compounds was then evaluated in vitro against a 
sensitive (K-562) and a multidrug resistant (Lucena-1) leukaemia cell lines, which 
overexpress the efflux pump glycoprotein P (P-gp), reducing the intracellular amount of 
anticancer drugs. The cytotoxic activities of the triterpenes are presented in the table 1 
and all the compounds were active against both sensitive and multidrug resistant cells 
[Rocha et al., 2007].  
Table 1 – Cytotoxic activities of the pentacyclic triterpenes isolated from C. lyratiloba  
Compound name 
Cytotoxic activity (µM) 
Reference 
K-562 Lucena-1 
Euscaphic acid IC50 = 76.71 ± 8.23 IC50 = 83.79 ± 4.17  
Rocha et al., 
2007 
Tormentic acid IC50 = 89.36 ± 2.23 IC50 = 80.25 ± 8.68  
2-α-Acetyl tormentic acid IC50 = 38.35 ± 5.29 IC50 = 41.38 ± 4.16  
3-β-Acetyl tormentic acid IC50 = 56.61 ± 9.95 IC50 = 72.87 ± 4.71  
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The group commented the structure/activity relationship of tormentic acid since acetylation 
at C2 increased the activity and acetylation at C3 resulted in a milder effect. Furthermore, 
the mechanism of action was determined using euscaphic acid by inducing apoptosis in k-
562 cells. The cell cycle analysis indicated that DNA fragmentation was dose dependent 
and was mediated by activation of caspase-3, which ultimately led to apoptosis. 
Euscaphic acid also reduced the viability of other human tumour cell lines, namely HEp-2 
(human larynx carcinoma cells), Caco-2 (human colon adenocarcinoma cells) and A-549 
(human breast carcinoma cells), with the IC50 values of 105.7 ± 0.39 μM, 104.1 ± 0.68 μM 
and 95.58 ± 5.14 μM respectively [Rocha et al., 2007]. 
Lately, the same group of researchers investigated the mechanism of antineoplastic 
action of 3-β-acetyl tormentic acid, this time using Lucena-1 cells, and they found that the 
compound induced apoptosis by activation of the intrinsic apoptotic pathway, which 
included DNA fragmentation, caspase-3 activation and cytochrome C release from 
mitochondria. Interestingly, the compound did not affect the expression of the efflux pump 
P-gp or its activity, and beyond this, the compound was not a substrate for the transporter 
since 3-β-acetyl tormentic acid was able to induce apoptosis in Lucena-1 cells. These 
findings together with the ability of other naturally occurring triterpenes to bypass 
resistance and to be active against multidrug resistant leukaemia cells suggested that 
these compounds may represent a potential therapeutic application in chronic myeloid 
leukaemia [Rocha et al., 2012]. 
2.4. Cecropia obtusifolia 
The plant Cecropia obtusifolia Bertol has been traditionally used for the treatment of type 
2 diabetes mellitus, especially in Mexico where it is widespread along both coasts 
[Andrade-Cetto and Heinrich, 2005]. Indeed, this traditional use justified the fact that the 
majority of C. obtusifolia reports have being related to its hypoglycaemic activity [Costa et 
al., 2011]. 
Interestingly, there are two published clinical trials that evaluated the clinical effect of the 
aqueous extract of C. obtusifolia, in order to confirm the folk therapeutic application of the 
plant. In the first clinical trial, the effects of the aqueous extract of C. obtusifolia were 
compared to the effects of the extract of Marrubium vulgare in type 2 diabetic people, 
whom were monitored the blood glucose and the plasma lipids levels. The results 
suggested that the aqueous extract of C. obtusifolia may be an adjunct treatment for type 
2 diabetic people with poor metabolic control, since it decreased the total serum 
cholesterol and triglycerides and it presented only mild and limited side effects. The trial 
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also indicated that C. obtusifolia was more effective than Marrubium vulgare for reducing 
the fasting blood glucose [Herrera-Arellano et al., 2004]. 
In the second clinical trial, the hypoglycaemic effect of C. obtusifolia was evaluated in 
recently diagnosed type 2 diabetic patients who were only controlled with diet and 
exercise.  The trial demonstrated a significant and sustained hypoglycaemic effect of the 
plant aqueous extract after 18 weeks of daily administration. The extract was not 
hepatotoxic, had no effect on the cholesterol or triglyceride levels and did not induce the 
insulin secretion [Revilla-Monsalve et al., 2007]. 
In addition to chlorogenic acid and isoorientin that have been reported as the most 
abundant compounds in C. obtusifolia extracts, being chlorogenic acid the acclaimed 
responsible for the hypoglycaemic activity, the compounds β-sitosterol (37), 
stigmasterol (38) [Andrade-Cetto and Heinrich, 2005], stigmast-4-en-3-one or β-
sitostenone (39), 4-cholestene-3,24-dione (40), 4,22-cholestadien-3-one (41), vanillic 
acid (42), 4-vinyl-2-methoxy-phenol (43), 2-methylbenzaldehyde (44), 2,3-
dihydrobenzofuran (45) and 3’-methoxyacetophenone (46) were also identified in C. 
obtusifolia [Guerrero et al., 2010]. 
 
Figure 11 – Structures of β-sitosterol (37), stigmasterol (38), stigmast-4-en-3-one (39), 4-
cholestene-3,24-dione (40), 4,22-cholestadien-3-one (41), vanillic acid (42), 4-vinyl-2-
methoxy-phenol (43), 2-methylbenzaldehyde (44), 2,3-dihydrobenzofuran (45) and 3’-
methoxyacetophenone (46) 
There are several biological studies that aimed to confirm the phytomedicinal value of C. 
obtusifolia and that tried to elucidate the mechanism of hypoglycaemic action. For 
example, in one study, the aqueous and butanolic extracts obtained from the leaves and 
the two identified and isolated chemical constituents, chlorogenic acid and isoorientin, 
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were tested in streptozotocin induced diabetic rats, showing significant hypoglycaemic 
effects 180 minutes after oral intake [Andrade-Cetto and Wiedenfeld, 2001]. 
In another study, Nicasio and colleagues investigated the hypoglycaemic activity of the 
methanolic extracts of C. obtusifolia and C. peltata and correlated this activity with the 
chlorogenic acid content of the extracts. They found that the hypoglycaemic effect was 
significantly different between the two species, since C. peltata showed a greater 
reduction in glucose level in non-diabetic rats and it was assumed that this effect was 
correlated to the highest content of chlorogenic acid in the methanolic extract of C. peltata 
[Nicasio et al., 2005]. 
None of the two mentioned studies have focussed on the elucidation of the mechanism of 
action, although some hypotheses have been suggested. In the attempt to understand the 
mechanism of action, Andrade-Cetto and co-workers tested the effect of C. obtusifolia 
extract on α-glycosidase activity in vitro and demonstrated that the extract presented a 
higher inhibitory activity than acarbose, a known α-glycosidase inhibitor. The authors 
assumed that one or more compounds existing in the extract inhibited the enzyme 
besides other possible mechanism [Andrade-Cetto et al., 2008].  
In another study, the antidiabetic mechanism of action of C. obtusifolia aqueous extract 
and its active compound chlorogenic acid were investigated in vitro for the glucose uptake 
in insulin-sensitive and insulin-resistant murine adipocytes. The results indicated that both 
extract and chlorogenic acid may exert their hypoglycaemic effect by mimicking or 
potentiating the action of insulin which stimulates the glucose uptake in adipocytes. The 
authors did not rule out the possibility of other compounds present in the aqueous extract 
may have the same action as chlorogenic acid [Alonso-Castro et al., 2008].  
In addition, the gluconeogenesis inhibitory effects of extracts from C. obtusifolia and C. 
peltata were tested in vivo by a pyruvate tolerance test performed in 18 hours-fasted rats 
and in vitro by inhibiting glucose-6-phosphate translocase in intact rat liver microsomes. 
On one hand, after a fasting period, the extracts of both plants and also chlorogenic acid 
were able to block the glucose production by administrating pyruvate, a source for hepatic 
glucose production. On the other hand, the IC50 values that were obtained for the extracts 
of both plants were similar, which suggested that the same compounds may be 
responsible for the enzyme inhibition and then for the blockade of gluconeogenesis. The 
group analysed the content of extracts by HPLC-DAD and they confirmed that chlorogenic 
acid and isoorientin were the main components on both plants [Andrade-Cetto and 
Vázquez, 2010].  
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As demonstrated, the interest of C. obtusifolia has been centred on its antidiabetic 
properties. However, other pharmacological effects were also reported for this specie. 
Indeed, for example in Panamá, C. obtusifolia has been traditionally used for the 
treatment of cardiovascular diseases like hypertension. Caballero-George and colleagues 
reported the in vitro effects of extracts obtained from leaves and stems of C. obtusifolia in 
the angiotensin II AT1 receptor, neuropeptide Y Y1 receptor and endothelin-1 ETA receptor 
by radioligand-binding techniques. All the receptors are involved in the vasoconstrictor 
phenomena when activated for endogenous ligands. As diverse extracts were tested, the 
AT1 receptors were competitively inhibited by the methanol:dichloromethane (1:1) extract 
obtained from the leaves (inhibition of 80 ± 16% at 100 μg/mL) and also by the 
methanol:dichloromethane (1:1) extract obtained from the stems (inhibition of 58 ± 2% at 
100 μg/mL). The tannin content was then removed from the stem extract in order to 
eliminate the nonspecific binding of these compounds. However, the effect was reduced 
to 20 ± 5% of inhibition at 100 μg/mL. The plant had almost no effect to Y1 receptors and 
the inhibition of ETA receptors for the ethanolic extracts was 51 ± 12% and 63 ± 7% when 
obtained respectively from the stems and the leaves [Caballero-George et al., 2001]. 
In another study, the vasoactive effects of C. obtusifolia collected in Panamá were also 
evaluated, this time, on endothelium-intact aortic preparations precontracted with 
phenylephrine. The results showed that the acid and neutral fractions of the methanolic 
and the dichloromethane extracts obtained from the aerial parts of the plant produced 
vasorelaxant effects, being about 50% of relaxation for the acid methanolic, neutral 
methanolic and acid dichloromethane fractions and about 20% of relaxation for the neutral 
dichloromethane fraction. In parallel, the group evaluated the inhibition of contractile 
responses to angiotensin II on endothelium-intact aortic rings isolated from spontaneously 
hypertensive rats, where they tested the same fractions. The group found that none of the 
fractions reduced the angiotensin II aortic contraction, which agreed with the in vivo 
findings of Lima-Landman et al. for C. glaziovii but contrasted with the reports of 
Caballero-George et al. in the in vitro blockade of AT1 receptors for C. obtusifolia. The 
differences may result from the extractive processes that may afford extracts with 
substantially different chemical contents [Guerrero et al., 2010]. 
Finally, the aqueous extract of C. obtusifolia was evaluated for its analgesic, anti-
inflammatory and SNC depressant effects in different experimental models. This study 
was based on the traditional uses of C. obtusifolia in El Salvador, since the plant leaves 
are used as sedative as well as anti-inflammatory and pain-killer for the treatment of 
arthritis and rheumatism. The aqueous leaf extract showed a substantial central depressor 
effect because it reduced the animal exploratory capacity, it suppressed the escape 
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capacity and produced significant motor incordination. The analgesic activity was only 
confirmed for the chemical stimuli tests and not for the hot plate test, which suggested the 
peripherial analgesic effect rather than the central analgesic effect. The study also 
demonstrated the topical and the systemic anti-inflamatory effects of the aqueous leaf 
extract of C. obtusifolia [Pérez-Guerrero et al., 2001]. 
2.5. Cecropia pachystachya 
As some of the aforementioned species of Cecropia, the plant Cecropia pachystachya 
Trécul has been also traditionally used in folk medicine as a cardiotonic and a diuretic 
herbal medicine, as well as for the treatment of cough and asthma [Consolini et al., 2005]. 
The leaves and barks of C. pachystachya are also used for its hypoglycaemic effects 
[Aragão et al., 2010]. The plant grows in the Neotropical regions of the Northeast of 
Argentina, Paraguay and the Southern region of Brazil. The plant also grows in the 
temperate hilly grasslands of central Argentina. The accepted phytomedicinal applications 
allowed the plant to be described in the sixth edition of the Argentinean National 
Pharmacopeia [Consolini and Migliori, 2005]. 
The effects of C. pachystachya were reported by Consolini and colleagues in two different 
papers, using samples collected in two phytogeographical regions of Argentina 
(Neotropical and temperate areas) in order to understand the impact of growing in 
different geographical areas on the pharmacological profile. In the first study, the group 
compared the in vivo cardiovascular effects on rats of the aqueous extracts obtained from 
the different geographical samples. The sample collected in the Neotropical area 
possessed stronger hypotensive effect than the sample collected in the temperate area. 
Another difference between the samples was their effects on heart rate, which was only 
increased by the temperate sample. However, none of the samples produced a diuretic 
effect on rats [Consolini and Migliori, 2005]. 
In the second study, the group evaluated the cardiac and the sedative effects of the plant. 
The aqueous extract obtained from the temperate area was tested on isolated cardiac 
preparations because this extract showed a positive chronotropic effect in the previous 
study. The group found a transitory positive inotropic effect on the isolated heart by 
measuring contractility at constant rate. Additionally, both aqueous extracts collected in 
the different geographical areas were evaluated in vivo on the open-field test, where they 
observed the exploratory behaviour and the spontaneous locomotion of mice. The 
Neotropical sample potentiated the anxiolytic dose of diazepam but not its sedative dose. 
However, both extracts showed a similar sedative effect that was not antagonized by 
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flumazenil, which suggested that the extracts may act in the GABA-A receptors but they 
not bind to the alosteric site of benzodiazepines [Consolini et al., 2006].  
The authors also performed a qualitative comparison in the chemical composition of both 
geographically distant extracts. The HPLC analysis did not reveal qualitative differences 
between the chromatographic profiles of the samples but it revealed quantitative 
differences as the areas of some peaks differed between chromatograms. By using a 
specific reagent in the TLC analysis, the group indicated that the chromatogram of the 
temperate sample presented six spots of flavonoids while the chromatogram of the 
Neotropical sample had only four spots of flavonoids [Consolini et al., 2006]. Despite the 
evidence presented, the content differences may be responsible for the differences in the 
pharmacological profiles of the samples. It is true that the chemical evaluation of the 
extracts was not the principal objective for the authors as they had referred, but further 
chemical investigation would be necessary to better understand the observed differences 
between the two geographical areas and to know the compounds that presented those 
activities.  
Unlike the previous study, the methanolic extract obtained from the leaves of C. 
pachystachya was initially analysed by TLC in another study, allowing the detection of two 
characteristic flavonoid colour spots. The HPLC-DAD analysis revealed the presence of 
chlorogenic acid and the flavonoids, orientin and isoorientin. The UV spectroscopic 
identification of the first compound was carried out by comparing with the reference 
compound and the flavonoid peaks were identified by comparing UV-DAD spectra with 
data found in literature. In this study, the researchers also evaluated the hypoglycaemic 
effect of C. pachystachya in normal and alloxan induced diabetic rats. The hypoglycaemic 
effect of the extract was observed and no significant difference was observed between 
animals treated with the extracts and those treated with oral antidiabetic drugs (metformin 
and glibenclamide) [Aragão et al., 2010]. 
The group of researchers Uchôa et al. evaluated several extracts of C. pachystachya 
obtained from different parts of the plant and conducted a bioassay-guided fractionation, 
testing their antimalarial activity against Plasmodium berghei in malaria-infected mice. The 
ethanolic extracts obtained from woods, roots and leaves reduced parasitemia of malaria-
infected mice. Because the root extract showed the strongest activity, this extract was 
further partitioned in subfractions and analysed in vivo. This bioguided assay resulted in 
the isolation of β-sitosterol and tormentic acid, which were in turn evaluated in vivo and 
also in vitro against the human parasite Plasmodium falciparum. The former compound 
showed a borderline activity whereas the latter compound effectively inhibited the parasite 
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growth, which indicated that this terpenoid may be a good candidate for the development 
of an antimalarial drug [Uchôa et al., 2010].   
The antiparasitic properties of C. pachystachya were also reported in another study. This 
time, the antileishmanial activity of the plant was evaluated by the inhibition of arginase, 
an enzyme that plays an important role in the biosynthesis of polyamines which are 
therefore required for cell proliferation. The Leishmania (Leishmania) amazonensis 
promastigote survival/proliferation and the in vitro arginase activity were investigated 
using the ethanolic extract of the plant and the subsequent subfractions obtained by the 
treatment with different solvents. The ethyl acetate fraction presented the best results for 
the inhibition of promastigote growth and the arginase inhibition, as well as, it changed the 
promastigote cellular organization which was observed by qualitative ultrastructural 
analysis. The major bioactive molecules of the ethyl acetate fraction were characterized 
as glycoside flavonoids using LC-ESI-MS. The group identified apigenin (47), orientin and 
isovitexin, being orientin the main component of the ethyl acetate fraction [Cruz et al., 
2013]. 
 
 Figure 12 – Structure of apigenin (47) 
The specie C. pachystachya was also studied for the anti-inflammatory, antinociceptive 
and cytotoxic effects. The anti-inflammatory activity of the methanolic leaf extract was 
tested in vivo in mice, both for oral and topical administrations. Therefore, the extract was 
not only effective per os and statistically similar to indomethacin, but also it presented an 
effect similar to dexamethasone when used topically. Additionally, the tests performed in 
vivo to evaluate the antinociceptive effect of the extract demonstrated that this effect might 
be achieved by decreasing the sensitivity of peripheral nociceptive receptors, which is 
characteristic of the lipoxygenase and cyclo-oxygenase inhibitors. Finally, the cytotoxic 
activity of the extract was evaluated against Jurkat cells (human T cell lymphoblast-like 
cells) and HL60 cells (human promyelocytic leukaemia cells), two wild-type leukaemia 
cells lines, along with HL60.Bcl-2 cells which are HL60 cells with ectopic expression of 
Bcl-2, known to be resistant to anti-cancer drugs. The effects of the extract on the viability 
of the panel of cancer cell lines are presented in the table 2, where are also presented the 
results for etoposide. This drug was not able to reduce the viability of HL60.Bcl-2 cells as 
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the extract did, which suggested that the extract may be composed for pro-apoptotic 
substances that interfere with the expression of the Bcl-2 family in HL60 cells [Aragão et 
al., 2013].  
Table 2 – Effect of the methanolic extract from C. pachystachya on the viability of the panel 
of cancer cell lines 
Extract / Compound 
% Inhibition of viability  
Reference 
HL60 cells HL60.Bcl-2 cells Jurkat cells 
Methanolic extract  56.9 ± 11.6 54.6 ± 2.5 5.1 ± 14.3 Aragão et 
al., 2013 Etoposide 80.8 ± 6.3 27.1 ± 12 69.2 ± 8.2 
There was another report on the cytotoxic activity of C. pachystachya. The leaf methanolic 
extract was tested towards B16 (murine melanoma cells), HL60, MCF-7 (human breast 
adenocarcinoma cells) and HCT-8 (human colon carcinoma cells). The table 3 presents 
the cytotoxic activity data of the extract, which inhibited the cellular proliferation of all the 
cell lines above 90% but the obtained IC50 values were above 125 μg/mL except for HL60 
cells [dos Santos Júnior et al., 2010].  
Table 3 – Cytotoxic activity data of the methanolic extract from C. pachystachya Trécul 
Cytotoxic activity 
Panel of tumour cell lines 
Reference 
B16 cells HL60 cells MCF-7 cells HCT-8 cells 
Cell growth inhibition 
percentage (GI%) (%) 
92.2 106.7 97.5 97.4 dos Santos 
Júnior et al., 
2010 50% inhibitory concentration 
(IC50) (μg/mL) 
> 125  95  > 125  > 125 
Besides the aforementioned studies with references to the chemical composition of the 
extracts, the specie also afforded pomolic acid (48), ursolic acid (49), oleanolic acid 
(50), α-amyrin (51), 19-α-hydroxy-α-amyrin (52) and β-sitostenone. The flavonoid O-
heteroside isoquercetrin was also reported in the C. pachystachya specie.  Addiitonally, 
the phenolic compounds chlorogenic acid and protocatechuic acid were also described for 
C. pachystachya.  Finally, the proanthocyanidins catechin, epicatechin, procyanidin B2 
and procyanidin C1 were also identified [Costa et al., 2011].  
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Figure 13 – Structures of pomolic acid (48), ursolic acid (49), oleanolic acid (50), α-amyrin 
(51) and 19-α-hydroxy-α-amyrin (52)  
2.6. Cecropia peltata 
The hypoglycaemic effect of Cecropia peltata L. was already mentioned in the 
corresponding section of C. obtusifolia, where that effect was compared between the 
plants in two different studies. Summarily, on one hand, the hypoglycaemic effect of C. 
peltata was superior to the effect of C. obtusifolia, which was correlated with the 
chlorogenic acid contents of the extracts [Nicasio et al., 2005]. On the other hand, extracts 
of both plants seemed to inhibit gluconeogenesis, which was evaluated in vivo and in vitro 
[Andrade-Cetto and Vázquez, 2010].   
Besides its hypoglycaemic effect, the specie C. peltata is also traditionally used for wound 
healing. The Nayak’s study regarded the wound-healing properties of the aqueous and 
ethanolic extracts, which where tested by topical and oral administration using the 
excision wound model in rats. The data showed that both extracts administrated by both 
routes reduced the wound areas. Additionally, the histopathologycal evaluation of the 
healing tissue obtained from the treated animals indicated a good organization of the 
tissue, which may indicate that some constituents of C. peltata extracts stimulate 
epithelialisation [Nayak, 2006].  
Finally, the antimicrobial activity of C. peltata was investigated in vitro against four 
bacteria (Staphylococcus aureus, Streptococcus β hemolitic, Bacillus cereus and 
Escherichia coli) and against yeast (Candida albicans). As showed in the table 4, the 
aqueous, the ethanolic and/or the hexane extracts of the plant were tested against the 
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refered microorganisms. The results corroborated with antimicrobial activity of C. peltata 
which is used in Colombian folk medicine to treat infections [Rojas et al., 2006]. 
Table 4 – Antimicrobial activity of C. peltata L. 
Extract 
Minimum inhibitory concentration (μg/mL) 
Reference Staphylococcus 
aureus 
Streptococcus β 
hemolitic 
Bacillus 
cereus 
Escherichia 
coli 
Candida 
albicans 
Aqueous 
extract 
NT NT NT 54.7 ± 6.8  NT 
Rojas et 
al., 2006 
Ethanolic 
extract 
16.6 ± 0.8  NT 14.9 ± 3.4 3.6 ± 0.2  NT 
Hexane 
extract 
NT 20.2 ± 2.9 NT 2.9 ± 0.6 21.5 ± 6.3  
NT: Not tested 
2.7. Cecropia schreberiana 
In this section, it will be presented a phytochemical investigation on the specie Cecropia 
schreberiana Miquel. The plant was identified by one of the authors of the original article, 
which reports the first chemical characterization of the phytochemical constituents of the 
specie C. schreberiana. The acetone crude extract obtained from the leaves was 
partitioned with different solvents and the resulting fractions were treated by diverse 
methods such as chromatography on silica gel open columns and semi-preparative RP-
HPLC. The plant afforded four triterpenoids that were pomolic acid, tormentic acid, α-
amyrin and arjunolic acid (53). The isolated flavone-C-glycosides were vitexin (54), 
orientin and isoorientin. Cinchonain Ia (55) and cinchonain Ib (56) were firstly isolated in 
the family Urticaceae. Finally, catechin and epicatechin were also isolated from the plant 
as well as the procyanidins B2 and B5. All the isolated compounds were identified by few 
methods, namely specific rotation, 1H and 13C NMR spectra, whose experimental data 
were compared with the data already reported [Li et al., 2013]. 
 
Figure 14 – Structures of arjunolic acid (53), vitexin (54), cinchonain Ia (55) and cinchonain 
Ib (56) 
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2.8. Cecropia catarinensis 
Unlike other species of the genus Cecropia, there are few descriptions on the traditional 
use of the specie Cecropia catarinensis Cuatrecasas. However, the authors Almeida et al. 
mentioned that the specie C. catarinensis has been used for the treatment of asthma and 
high blood pressure and it is also used as a diuretic and an antispasmodic agent [Almeida 
et al., 2006]. Additionally, the specie has not been much studied, which indicates that the 
folk medicine applications of the plant have not been scientifically checked yet. In fact, 
concerning the evaluation of the cytotoxic and the microbial activities of the plant, we are 
the first group to investigate the extracts, fractions and the pharmacologically active 
components of the specie for the aforementioned activities. However, before moving on to 
the study of our plant, it is important to identify a study that focussed on the chemical 
investigation of the plant, which was conducted Machado and colleagues.  
Therefore, the article reported the phytochemical study of roots stems and leaves of the 
plant, which afforded a total of eight compounds. The roots were successively extracted 
with hexane, dichloromethane and ethyl acetate. The hexane extract yielded β-sitosterol 
and 2α-acetyl tormentic acid. The compounds 2α-acetyl euscaphic acid (57), 2α-
acetoxy-3β,19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide (58) and 3β-acetoxy-
2α,19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide (59) were isolated from the 
dichloromethane extract as well as tormentic acid and an inseparable mixture of ursolic 
and oleanolic acids. The ethyl acetate extract afforded further amounts of tormentic acid, 
2α-acetyl tormentic acid, 2α-acetoxy-3β19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide, 
3β-acetoxy-2α,19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide and 2α-acetyl euscaphic 
acid and also euscaphic acid, pomolic acid and 2α,3α,23-trihydroxy-olean-12-en-28-oic 
acid (60). The stems were similarly treated as the roots were, yielding the same 
compounds except 2α-acetoxy-3β19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide and 
3β-acetoxy-2α,19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide. Finally, the leaves were 
extracted with methanol and then partitioned between hexane and a mixture of methanol 
and water (9:1). This last fraction was evaporated and extracted with chloroform, giving a 
mixture of triterpenes, and then with butanol, affording a mixture of C-flavonoid glycosides 
(vitexin, isovitexin, orientin and isoorientin) [Machado et al., 2008].  
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Figure 15 – Structures of 2α-acetyl euscaphic acid (57), 2α-acetoxy-3β,19α-dihydroxy-
11α,12α-epoxy-ursan-28,13β-olide (58), 3β-acetoxy-2α,19α-dihydroxy-11α,12α-epoxy-ursan-
28,13β-olide (59) and 2α,3α,23-trihydroxy-olean-12-en-28-oic acid (60) 
As noted throughout this chapter, it is possible that some of the mentioned compounds 
may be isolated or identified in our plant. However, the specie C. catarinensis is still poorly 
studied, which increases the hypothesis of finding unpublished secondary metabolites for 
this specie. The next chapter corresponds to the experimental procedures of the present 
biological and chemical studies of our plant material. 
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Chapter 3 
Experimental procedures 
 
 
 
 
 
 
  
  
  
   
 
 
 
 
 
 
 
 
 
 
http://www.ls.wisc.edu/research-ors.html; 
http://www.picstopin.com; 
http://www.dreamstime.com/stock-image-96-well-plate-beaker-image5595471; 
http://www.bacto.com.au/culture-media/. 
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3. Experimental procedures 
3.1. Materials and methods 
Silica gel column chromatography (0.04 – 0.063 mm, Mn silica gel 60 M, Machery-Nagel) 
was used to purify the CME1 and the groups G4 and G5.  
For preparative TLC, chromatographic plates (20 x 20 cm, 0.25 mm thickness) were 
prepared in the laboratory with silica gel 60 GF254 (Merck) as stationary phase.  
For analytical TLC, those prepared chromatographic plates were also used, as well as, 
the pre-coated aluminium sheets (20 x 20 cm) Alugram® Sil G/UV254 (Machery-Nagel).  
To elute both analytical TLC and preparative TLC, it was added 6 six drops of formic acid 
to each 100 mL of eluent. 
Both analytical TLC and preparative TLC were physically revealed with UV lamps at 254 
nm and 365 nm and were chemically developed by spraying a mixture of sulphuric acid 
and methanol (4:1); the plates or the pre-coated sheets treated with the referred mixture 
were then heated at 100ºC for 5-6 minutes. In the preparative TLC, the chemical 
development was only executed in a thin portion of the left border of the plate. 
The used solvents were petroleum ether 60-80º (Merck), dichloromethane (VWR), 
chloroform (VWR), acetone (Atom Scientific; Carlo Erba) and methanol (VWR, Sigma-
Aldrich). All the solvents possessed the “pure” or “pro-analysis” degree of purity.  
Solvents were evaporated at reduced pressure, using a waterbath Büchi B-480 at 40ºC, a 
rotavapor Büchi R-114 and a vacuum controller Büchi V-850. 
Melting points were obtained on a Köfler microscope and were uncorrected.  
GC-MS analysis was performed in a Finnigan GC-MS system. The chromatographer was 
a Trace GC 2000 Series (ThermoQuest CE Instruments), the mass spectrometer coupled 
was a GCQPlus Finnigan (ThermoQuest) and the software for data acquisition and 
treatment was Xcalibur® 1.0. The capillary column was Rtx® - 5MS (Restek Crossbond® 
5% diphenyl-95% dimethylpolysiloxane), with 30 metres, 0.25 mm of internal diameter and 
0.25 μm df, and with an intermediate polarity. The vector gas was helium, scoring 1.5 
ml/min. The chromatographer operated in the following conditions:  injection in a splitless 
mode; volatilisation temperature at 250°C; oven’s initial temperature of 80°C for 5 
minutes, increasing 10°C/min until the final temperature of 300°C. For the mass 
spectrometer, the transference line temperature was 275°C and the ion source 
temperature was 210°C; the ionization was achieved by electronic impact at 70eV and the 
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analyser was an “ion trap” type. For the qualitative analysis, the detector was used in TIC 
(total ion chromatogram) mode, with a mass interval m/z = 50-650. 
1H and 13C NMR spectra were recorded in deuterated chloroform or deuterated DMSO 
(Deutero GmbH) at room temperature on a Bruker Avance-300 MHz instrument operating 
at 300.13 and 75.47 MHz, respectively. Chemical shifts were represented as ppm (δ). The 
coupling constants (J) were represented in Hertz (Hz). 
The antifungal and antibacterial activities were evaluated according to the clinical and 
laboratory standards institute (CLSI) for the determination of MIC (minimum inhibitory 
concentration) and MLC (minimum lethal concentration) by a broth microdilution method.  
The in vitro growth inhibition activities were evaluated on three human tumour cell lines 
(MCF-7, NCI-H460 and A375-C5 cells), according to the procedure adopted in the NCI for 
the “In vitro anticancer drug screening” - SRB assay. The absorbance measurement at 
492 nm was performed in the microplate reader BIORAD 680 model and the absorbance 
values were retrieved using Gene5 software (Biotek). 
3.2. Plant material 
The leaves of Cecropia catarinensis were collected in Mendes (Rio de Janeiro, Brazil) by 
Professor Douglas Siqueira de Almeida Chaves from the Universidade Federal Rural do 
Rio de Janeiro (Brazil) and were identified by Professor Jorge Pedro Carauta. A voucher 
specimen was deposited in the Museu Nacional do Rio de Janeiro (Brazil) under the 
number R212.173.  
3.3. Chemical studies 
3.3.1. Extraction and treatment of the leaf crude extract 
The leaves of C. catarinensis were dried during 78 hours at room temperature and the 
dried material was then mechanically triturated. The extractive procedure is schematized 
in the figure 16. The crude methanolic extract (CME) was obtained using 1 kg of the 
triturated material of C. catarinensis by exhaustive extraction with 5 L of methanol at room 
temperature. The obtained macerate was filtered and concentrated at reduced pressure 
by evaporating the solvent, which yielded 152.22 g of CME.  
In the next step, 150.29 g of CME were treated with 10 L of dichloromethane and were 
exhaustively extracted at room temperature. The resulting soluble fraction was then 
filtered and concentrated at reduced pressure, which yielded 11.60 g of a fraction 
identified as F1. The resulting insoluble fraction was in turn treated with 11 L of ethyl 
acetate, which afforded a soluble fraction that was also filtered and concentrated at 
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reduced pressure, yielding 28.13 g of a fraction identified as F2. The fractions F1 and F2 
were analysed by TLC and had a similar chromatographic profile, which allowed the 
combination of both fractions to give a less polar semi-purified fraction named CME1 
(38.20 g).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 – Extractive process of the dried plant material and treatment of the methanolic 
crude extract 
The insoluble residue that resulted from the treatment and extraction with ethyl acetate 
was finally concentrated at reduced pressure, yielding 109.75 g of a polar semi-purified 
fraction that was identified as CME2. 
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3.3.2. Purification of the non-polar extract CME1 
The semi-purified fraction CME1 with lower polarity was chemically investigated in order 
to isolate active compounds. The purification process started with a chromatography on 
silica gel column which was eluted with organic solvents (petroleum ether, 
dichloromethane, acetone and methanol) and mixtures of them by increasing the gradient 
of polarity. The table 5 resumes the fractionation process of CME1.  
Table 5 – Fractions obtained from the purification of CME1 
Fractions Eluents  
F1 – F28 Petroleum ether 60-80º 
F29 – F52 Petroleum ether 60-80º +  dichloromethane (9:1) 
F53 – F83 Petroleum ether 60-80º +  dichloromethane (7:3) 
F84 – F109 Petroleum ether 60-80º +  dichloromethane (1:1) 
F110 – F143 Petroleum ether 60-80º +  dichloromethane (3:7) 
F144 – F183 Petroleum ether 60-80º +  dichloromethane (1:9) 
F184 – F208 Dichloromethane 
F209 – F242 Dichloromethane + acetone (9:1) 
F243 – F270 Dichloromethane + acetone (7:3) 
F271 – F296 Dichloromethane + acetone (1:1) 
F297 – F324 Dichloromethane + acetone (3:7) 
F325 – F337 Acetone 
F338 – F346 Acetone + methanol (9:1) 
F347 Methanol 
This column chromatography produced 347 fractions of 250 mL that were then gathered 
in 14 groups (G1 to G14) according to the chromatographic profile of the fractions 
evaluated by TLC analysis. The table 6 identifies the groups, the fractions and the weight 
of each group. The yield of the process was 88.38%. 
Table 6 – Groups obtained from the fractionation of CME1  
Groups Fractions Weight (g) 
G1 F1 – F15 1.890 
G2 F16 – F45 0.145  
G3 F46 – F106 1.115  
G4 F107 – F140 0.645  
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Table 6 (continued) – Groups obtained from the fractionation of CME1  
Groups Fractions Weight (g) 
G5 F141 – F182 0.566  
G6 F183 – F208 0.216  
G7 F209 – F214 2.020  
G8 F215 – F231 1.864  
G9 F232 – F242 0.680  
G10 F243 – F296 8.920  
G11 F297 – F324 2.910  
G12 F325 – F337 1.080  
G13 F338 – F345 1.160  
G14 F346 – F347 10.550  
3.3.2.1. Purification of group G2 
Since the group G2 weighted 0.145 g, the purification of G2 started with a first preparative 
TLC. The sample was dissolved using a mixture of petroleum ether and dichloromethane 
(3:7) and the chromatographic eluent was a mixture of petroleum ether and 
dichloromethane (1:9). After revelation with UV lamp (254 nm), the target fraction (Rf 
0.23) was collected and extracted with a mixture of petroleum ether and dichloromethane 
(3:7), yielding 0.053 g. 
According to the analytical TLC of that first purification step, the target fraction needed to 
be re-purified. The re-purification of that fraction was carried out by another preparative 
TLC that was performed with a mixture of petroleum ether, dichloromethane and acetone 
(1:8:1) as eluent. After revelation with UV lamp (254 nm), the target fraction (Rf 0.82) was 
then extracted with a mixture of petroleum ether and dichloromethane (3:7). This second 
putrification step resulted in the isolation of compound 1 (0.013 g).  
3.3.2.2. Purification of group G4+5 
A previous analytical TLC of the groups G4 (0.645 g) and G5 (0.566 g) demonstrated that 
both groups could be combined in the same purification process. Therefore, the groups 
were fractionated together in the same column as a new fraction G4+5 (1.211 g), using 
160 g of silica gel. The sample was dissolved in a mixture of petroleum ether and 
dichloromethane (3:7) and the column was eluted with different mixtures of solvents in an 
increasing gradient of polarity. The fractions were eluted from the column as indicated in 
the table 7 and 516 fractions were collected with 50 mL each one. 
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Table 7 – Fractions obtained from the purification of group G4+5  
Fractions Eluents  
F1 – F90 Petroleum ether 60-80º +  dichloromethane (3:7) 
F91 – F267 Petroleum ether 60-80º +  dichloromethane (1:9) 
F268 – F317 Dichloromethane + acetone (9:1) 
F318 – F348 Dichloromethane + acetone (7:3) 
F349 – F376 Dichloromethane + acetone (1:1) 
F377 – F392 Dichloromethane + acetone (3:7) 
F393 – F409 Acetone  
F410 – F448 Acetone + methanol (7:3) 
F449 – F472 Acetone + methanol (1:1) 
F473 – F491 Acetone + methanol (3:7) 
F492 – F516 Methanol 
The collected fractions were monitored by analytical TLC and the fractions were combined 
according to their chromatographic profile as indicated in the table 8. The yield of the 
process was 78.53%.  
Table 8 – Combined fractions from the purification of group G4+5  
Combined fractions  
Identification Weight (g) 
F1 – F33 0.039  
F34 – F44 0.006  
F45 – F99 0.051  
F100 – F118 0.012  
F119 – F178 0.030  
F179 – F194 0.015  
F195 – F274 0.101  
F275 – F298 0.206  
F299 – F324 0.227  
F325 – F479 0.240  
F480 – F516 0.024  
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The analytical TLC indicated a target compound between fractions 45 to 99 (0.051 g). 
Since the compound was insoluble in acetone, we proceeded to a solid-liquid extraction 
with acetone and the supernatant was separated from the compound. This procedure 
produced a pure compound that was codified as compound 2 (0.048 g). 
3.3.2.3. Purification of group G6 
The group G6 was purified by a preparative TLC using a mixture of dichloromethane and 
acetone (9:1) as eluent. After development with sulphuric acid, the target fraction (Rf 0.60) 
was extracted with pure dichloromethane, yielding 0.043 g.  
The TLC analysis of that fraction indicated that it needed to be re-purified. The fraction 
was subjected to another preparative TLC using the same eluent and the same extractive 
solvent as the first purification step. Unfortunately, the resulting fraction (0.015 g) required 
an additional purification step.  
The third preparative TLC was eluted with a mixture of dichloromethane and acetone 
(19:1) and pure dichloromethane was once again used to extract the target fraction (Rf 
0.76). Therefore, the purification of G6 was performed with three consecutive preparative 
TLC that resulted in the isolation of compound 3, yielding 0.008 g of this compound.   
3.3.2.4. Purification of group G8 
In a small aliquot (0.1 g) of G8, it was observed a deposition of a white solid. This solid 
was firstly treated with petroleum ether (5 x 2 mL) and the supernatant was separated 
from the solid. The solid was then treated with a mixture of dichloromethane and acetone 
(1:1) (5 x 2 mL) and the supernatant was again separated from the solid. The resulting 
solid was codified as compound 4 (0.010 g).  
The same procedure was carried out on a larger scale (5 x 30 mL) of G8 (1.863 g), which 
yielded 0.149 g of compound 5.  
The figure 17 consists in a scheme that resumes the methodology employed for the 
purification of the groups G2, G4+5, G6 and G8. 
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Figure 17 – Purification procedures of groups G2, G4+5, G6 and G8 
3.4. Biological studies 
3.4.1. Evaluation of the antimicrobial activity 
The antimicrobial activities of the plant extracts and the isolated compounds were 
performed against the microorganisms identified in the next sections.  
3.4.1.1. Antifungal activity 
The broth microdilution method is based on CLSI reference protocols M27-A3 for yeasts 
(Candida albicans) and M38-A2 for filamentous fungi (Aspergillus fumigatus and 
dermatophytes) and is used to obtain the MIC and the MLC of the isolated compounds 
and the plant extracts. The MIC is the lowest concentration of the compound that inhibits 
the growth of microorganisms and the MLC is the lowest concentration that kills 99.9% of 
the microorganisms. 
The microorganisms used for the antifungal assays were Candida albicans ATCC 10231, 
Aspergillus fumigatus ATCC 46645 and Trichophyton rubrum FF5 (clinical strain). 
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The stock solutions of the plant extracts and the isolated compounds were prepared with 
DMSO and the test solutions were freshly prepared and added to the cell suspensions, 
obtaining test concentrations that range from 16 to 256 μg/mL. Fluconazole and 
amphotericin B were used as positive controls. Negative controls corresponded to 
untreated microorganisms and the effect of DMSO on the microorganisms was also taken 
into account. It was also employed a sterility control. 
The microorganisms were aerobically incubated under the following conditions: 35ºC ± 
0.2ºC in atmospheric humidity during 24h/48h for C. albicans and A. fumigatus, and at 
25ºC ± 0.2ºC in atmospheric humidity during 5 days for T. rubrum. 
The yeast cell suspensions were prepared in 0.85% NaCl and the transmittance of cell 
density was adjusted to the 0.5 McFarland standards for C. albicans. Cell suspensions 
were diluted with RPMI 1640 in order to achieve an inoculum size of 1 - 5 x 103 CFU/mL. 
For the filamentous fungi, the spore suspensions were prepared in 0.85% NaCl with 
tween 80 and the cell density was adjusted at 20-250 conidia/squares (haemocytometer) 
for A. fumigatus and 20 - 60 conidia/squares for T. rubrum. Similarly, the spore 
suspensions were diluted with RPMI 1640 in order to achieve an inoculum size of 0.4 - 5 x 
104 CFU/mL and 1 - 3 x 103 CFU/mL for A. fumigatus and for T. rubrum, respectively. 
MIC values were found as the lowest concentration of the selected compound or extract 
that revealed 100% growth inhibition. Besides, a quality control was performed by testing 
the inhibitory activity of fluconazole with the reference strain C. parapsilosis ATCC 90018 
(CLSI standard for MIC = 0.5 - 2 μg/mL). To evaluate MLC values, after MIC 
determination, 20 μL samples were taken from each negative well and the growth control 
was the first well that exhibited growth. The samples were applied on SDA (Sabouraud 
dextrose agar) plates and incubated at 35ºC ± 0.2ºC for 24h/48h (C. albicans and A. 
fumigatus) or at 25ºC ± 0.2ºC for 7 days (T. rubrum). MLC values corresponded to the 
lowest concentration of the selected compounds causing fungal death. All experiments 
were repeated three times and were always performed in duplicate. 
3.4.1.2. Antibacterial activity 
Regarding the antibacterial activity, the broth microdilution method was based on CLSI 
reference protocol M7-A7. The bacteria tested for the plant extracts and all the isolated 
compounds were Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus ATCC 25923 and the methicillin-resistant Staphylococcus aureus 
(MRSA) (clinical isolate). Additionally, the bacteria Enterococcus faecalis ATCC 29212 
and Bacillus cereus NCTC 7587 were also tested for selected compounds. 
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Cell suspensions were prepared in 0.85% NaCl and the transmittance of cell density was 
adjusted to the 0.5 McFarland standards in order to achieve an inoculum size of 105 
CFU/mL. The dilutions of the cells suspensions were obtained adding MHB (Muller-Hinton 
broth). 
The stock solutions of the plant extracts and the isolated compounds were also prepared 
in DMSO and were diluted in serial two-folds with MHB in order to obtain the final 
concentrations that ranged from 16 to 256 μg/mL.  
Gentamicin was used as positive control. Negative controls, DMSO control and sterility 
control were also employed. The plates were aerobically incubated at 35 ± 0.2ºC in 
atmospheric humidity for 16h/20h.  
Similarly, MIC values were determined as the lowest concentration of the selected 
compound or extract that revealed 100% of growth inhibition. Besides, a quality control 
was performed by testing the inhibitory activity of gentamicin against E. coli ATCC 25923 
(CLSI standard for MIC = 0.25 - 1 μg/mL) as well. MLC values were obtained after MIC 
determination, in which 20 μL samples were taken from each negative well and the growth 
control was the first well that exhibited growth. The samples were also applied on MHA 
(Muller-Hinton agar) plates and were incubated at 35 ± 0.2ºC for 24h. MLC values 
corresponded to the lowest concentration of the selected compounds or extracts that 
caused bacterial death.  All experiments were performed in duplicate and were repeated 
three times, yielding essentially the same results. 
3.4.2. In vitro growth inhibition of human tumour cell lines 
The growth inhibition effects of the methanolic crude extract (CME) and the semi-purified 
fraction CME1 and CME2 were tested for their in vitro growth inhibitory effects against a 
selected panel of cancer cell lines (MCF-7, NCI-H460 and A375-C5 cells).  
The source of MCF-7 and A375-C5 cell lines was the European collection of cell cultures 
(ECACC) and the NCI-H460 cell lines was an offer from NCI, Bethesda, USA. 
The cell lines were routinely maintained in RPMI-1640 medium, which was supplemented 
with 5% of FBS, at 37ºC in a humidified atmosphere containing 5% of CO2. The cell 
number and the viability of the cell lines were routinely determined with Trypan blue 
exclusion assay (Sigma). All the experiments were performed with cells presenting more 
than 90% of viability in an exponential growth. 
The stock solutions of the plant extracts were aseptically dissolved in DMSO and stored at 
-20ºC. The appropriated dilutions of those stock solutions were freshly prepared just prior 
to be used for the assays and were diluted using the growth medium. 
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The in vitro growth inhibition assays were performed using a procedure adopted in the 
NCI in the “In vitro anticancer drug discovery screen”, which employs the protein-binding 
dye SRB to assess cell growth [Monks et al., 1991]. Therefore, this colorimetric assay 
indirectly estimates the cell number by staining cellular protein, which is evaluated by the 
absorbance measurement at 492 nm in the microplate reader.  
The cell lines were plated in an appropriate density (MCF-7 and NCI-H460 cells were 
plated at 5 x 103 cells/well and A375-C5 cells were plated at 7.5 x 103 cells/well) and were 
allowed to be attached for 24 hours in the 96 well-plates. The exponential growing cells 
were further exposed to the selected compounds at increasing concentrations and to the 
positive control doxorubicin. The cells were incubated for 48 hours at 37ºC and 5% of 
CO2. After this incubation period, the adherent cells were fixed in situ with 10% 
trichloroacetic acid, washed with 1% acetic acid and stained with SRB. The protein-SRB 
complexes were solubilised with 10 mM of Tris buffer and the absorbance was then 
measured.  
For each cell line, a dose-response curve was obtained and the concentration that 
inhibited cell growth in 50% (GI50) was calculated according to the adopted procedure 
[Monks et al., 1991]. The effect of the vehicle solvent (DMSO) on the growth of these cell 
lines was also determined because untreated control cells were exposed to the maximum 
concentration of DMSO (0.25%) that was used in each assay. All the experiments were 
repeated at least three times and were always performed in duplicate.  
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Chapter 4 
Results and discussion 
 
 
 
 
 
 
  
  
  
   
 
 
 
 
 
 
 
 
 
http://wallpoper.com/wallpaper/chemistry-343472; 
http://www.pzccc.com/competition.php; 
http://www.dreamstime.com/stock-image-96-well-plate-image5595411; 
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822009000200002.  
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4. Results and discussion 
4.1. Chemical studies 
The isolated compounds were always analysed by TLC before proceeding to additional 
chemical studies. The table 9 compiles the analytical TLC results obtained for each 
compound.  
Table 9 – Analytical TLC data of compounds1 to 5 
Isolated 
compounds  
Analytical TLC data  Plate revelation 
Eluent  Rf 
UV  
254 nm 
UV  
365 nm 
H2SO4 
Compound 1 
Petroleum ether +  
Dichloromethane + Acetone 
(1:18:1) 
0.82 
Pronounced 
quenching 
--- --- 
Compound 2 Dichloromethane + Acetone (9:1) 0.59 --- --- 
Reddish 
pink 
Compound 3 Dichloromethane + Acetone (19:1) 0.68 --- --- Burgundy 
Compound 4 Dichloromethane + Acetone (9:1) 0.48 --- --- 
Brownish 
pink 
Compound 5 
(mixture) 
Dichloromethane + Acetone (9:1) 
0.48 
0.52 
--- --- 
Brownish 
pink & pink 
The compounds were then identified based on their 1D and 2D NMR spectral analysis 
and/or by GC-MS analysis. In the NMR spectral analysis, the chemical shifts (δ) are 
expressed in ppm. In the analysis made to the 1H NMR spectra, the corresponding 
coupling constants (J, Hz) were taken into account to establish the structures of the 
isolated metabolites. 
4.1.1. Structure elucidation of compound 1 
Compound 1 was isolated as white solid (13 mg). The chromatographic profile showed 
one single spot with Rf = 0.82 (petroleum ether + dichloromethane + acetone – 1:18:1). It 
was identified a pronounced quenching when the compound was observed under UV 
lamp (254 nm), indicating that there would be a delocalised π system in its molecular 
structure.  
The analysis of the 1H NMR spectrum at 300 MHz in CDCl3 allowed the identification of a 
singlet of one olefinic proton at δH 5.72 and the observation of a complex pattern of 
signals between 0.5 and 2.5 ppm. 
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The 13C NMR spectrum revealed the presence of twenty-nine (29) carbon signals, a signal 
at δC 199.79 that was probably related with a carbonyl carbon and two olefinic carbons at 
δC 171.84 and δC 123.69. The carbonyl group and the double bond were presumably 
conjugated, which justify the absorption at 254 nm. 
Based on the data above, it was conducted a literature survey that showed the 13C-NMR 
data of compound 1 were very similar with those published for β-sitostenone as shown in 
table 10. 
Table 10 – 
13
C NMR data of compound 1 and 
13
C NMR data described in the literature 
Carbons 
Compound 1 
Prachayasittikul et 
al., 2009 
Carbons 
Compound 1 
Prachayasittikul et 
al., 2009 
δC (CDCl3 75 MHz) δC (CDCl3 125 MHz) δC (CDCl3 75 MHz) δC (CDCl3 125 MHz) 
C-1 35.63 36.06 C-16 28.17 28.13 
C-2 33.96 33.93 C-17 55.81 55.99 
C-3 199.79 199.58 C-18 11.94 11.90 
C-4 123.69 123.69 C-19 18.66 18.65 
C-5 171.84 171.64 C-20 36.08 36.07 
C-6 33.80 33.86 C-21 18.97 18.98 
C-7 31.99 32.91 C-22 35.91 35.65 
C-8 35.58 35.60 C-23 25.92 26.08 
C-9 53.74 53.79 C-24 45.73 45.81 
C-10 39.55 39.59 C-25 29.03 29.64 
C-11 20.97 21.10 C-26 20.91 20.99 
C-12 38.56 38.57 C-27 19.81 19.75 
C-13 42.33 42.35 C-28 22.99 23.04 
C-14 55.92 55.85 C-29 11.92 11.14 
C-15 24.15 24.14  
The presented data and the 2D NMR analisys allowed to suggest that compound 1 might 
be β-sitostenone. In order to support this suggestion, it was determined the melting point 
of compound 1 and the value was in good agreement with that in literature (mp 96-97ºC) 
[Prachayasittikul et al., 2009]. 
Nevertheless, the compound was also analysed by GC-MS and the chromatogram 
presented a single peak at the retention time of 34.27 minutes. The molecular ion 
corresponded to the 412.6 m/z peak in the mass spectrum. As represented in the figure 
18, the characteristic peaks were given at 271.4 m/z (which corresponded to the loss of 
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the side chain), at 229.4 m/z (which resulted from the fragmentation of the ring D between 
C13 – C17 and C14 – C15) and at 124.2 m/z (which resulted from the fragmentation of 
the ring B between C9 – C10 and C6 – C7) [Zaretskii et al., 1967]. However, it is still 
necessary to determine the optical rotation of compound 1 and to compare with the 
literature data. 
 
Figure 18 – Fragmentation scheme of β-sitostenone 
As mentioned in the chapter 2, β-sitostenone was already reported within the Cecropia 
genus in the species C. obtusifolia [Guerrero et al., 2010] and C. pachystachya [Costa et 
al., 2011]. However, it is the first time that the compound is isolated from C. catarinensis. 
4.1.2. Structure elucidation of compound 2 
Compound 2 was isolated as white solid (51 mg). The analytical TLC of this compound 
showed that it presented the same retention factor (Rf = 0.59; eluent: dichloromethane + 
acetone – 9:1) as a sample of β-sitosterol used in the laboratory, developing the same 
reddish pink colour when treated with sulphuric acid. The NMR data of this sample of β-
sitosterol is given in the annex 1.  
In order to confirm that suspicion, the compound was analysed by GC-MS. The gas 
chromatogram of compound 2 showed a single peak (RT = 32.49 min) and its mass 
spectrum was screened in the software library, indicating that it was β-sitosterol with the 
highest probability (26.30%).  
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The molecular mass of β-sitosterol is 414.7, which explained the peak at 414.7 m/z. 
Several characteristic peaks could be identified, depending on the loss of the hydroxyl 
group from the ring A. Firstly, the peaks 273.4 m/z and 231.4 m/z occurred in the absence 
of hydroxyl group loss as identified in the figure 19. Secondly, the peaks 255.4 m/z and 
213.4 m/z arose if dehydration occurs [Kamboj and Saluja, 2011; Zaretskii et al., 1967].  
 
Figure 19 – Fragmentation scheme of β-sitosterol 
The melting point of compound 2 was 137-139ºC, which was in accordance to literature 
[Chaturvedula and Prakash, 2012]. In any case, the GC-MS analysis did not provide an 
absolute structure elucidation of compound 2 but it prevented the determination of NMR 
spectra since β-sitosterol is a trivial compound that has been widely studied. 
4.1.3. Structure elucidation of compound 3  
Compound 3 was isolated as white crystal (8 mg). In the TLC analysis, the compound 
developed a burgundy colour (Rf = 0.68; eluent: dichloromethane + acetone - 19:1) when 
developed with sulphuric acid.  
  
 Cecropia catarinensis Cuatrecasas (Urticaceae): Chemical and biological studies 
 
- 57 - 
 
The analysis of the 1H NMR spectrum at 300 MHz in CDCl3 indicated a complex area 
between 0.5 and 2.0 ppm. In addition, the following characteristic signals allowed us to 
propose a pentacyclic triterpene pattern: a triplet of one olefinic proton at δH 5.14 (J = 3.5 
Hz); a doublet of one proton at δH 3.55 (J = 11 Hz) that correlated to another proton at δH 
3.19 (J = 11 Hz); and a double doublet at δH 3.24 (J1 = 11 Hz and J2 = 5.5).  
The 13C NMR spectra revealed the presence of thirty (30) carbon signals. We highlight the 
signals at δC 125.0 and δC 138.7 that could correspond to two olefinic carbons, and the 
signals at δC 69.9 and δC 78.9 that might indicate two unprotected carbons, which were 
probably bonded to a deprotecting element like oxygen. The 13C NMR data suggested an 
ursane type skeleton, which could probably be the structure of uvaol. In order to verify this 
suggestion, the 13C NMR data of compound 3 were compared to the 13C NMR data for 
uvaol published by Zhang and colleagues (table 11). 
Table 11 – 
13
C NMR data of compound 3 and 
13
C NMR data described in the literature 
Carbons 
Compound 3  Zhang et al., 2012 
Carbons 
Compound 3  Zhang et al., 2012 
δC (CDCl3 75 MHz) δC (CDCl3 125 MHz) δC (CDCl3 75 MHz) δC (CDCl3 125 MHz) 
C-1 38.7 38.3 C-16 23.2 22.8 
C-2 27.2 26.7 C-17 37.9 38.3 
C-3 78.9 78.5 C-18 53.9 53.5 
C-4 36.8 37.4 C-19 39.3 38.8 
C-5 55.1 54.7 C-20 39.4 39.0 
C-6 18.3 17.9 C-21 34.0 34.6 
C-7 32.8 32.4 C-22 30.6 30.1 
C-8 39.9 39.6 C-23 28.1 27.5 
C-9 47.6 47.1 C-24 15.7 15.1 
C-10 35.1 36.3 C-25 15.3 15.1 
C-11 23.3 22.8 C-26 16.7 16.3 
C-12 125.0 124.5 C-27 23.3 22.8 
C-13 138.7 138.1 C-28 69.9 69.4 
C-14 41.9 41.4 C-29 17.3 16.8 
C-15 25.9 25.5 C-30 21.3 20.8 
Additionally, the data obtained from the 2D NMR spectra were in accordance to our 
proposal, and the melting point (226-229ºC) was also coincident [Zhang et al., 2012]. The 
chemical structure of uvaol (65) is represented in the figure 20. However, it is still 
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necessary to determine the optical rotation of compound 3 and to compare with the 
literature. 
 
Figure 20 – Structure of uvaol (61) 
It is important to note that uvaol has never been isolated within the genus Cecropia, so it 
is the first time that the compound is described in the genus and in the specie C. 
catarinensis. 
4.1.4. Structure elucidation of compound 4  
Compound 4 was isolated as white solid (10 mg). In the TLC analysis, the compound 
developed a brownish pink colour (Rf = 0.48; eluent: dichloromethane + acetone - 9:1) 
when developed with sulphuric acid. 
The analysis of the 1H NMR spectrum at 300 MHz in deuterated DMSO allowed us to 
propose a pentacyclic triterpene pattern: one olefinic proton at δH 5.16; one proton at δH 
4.30 that probably belonged to an hydroxyl group; a proton at δH 3.00 that could be 
bounded to the same oxymethinic carbon as the referred hydroxyl group; and a complex 
area of signals between 0.68 and 0.9 ppm.  
Although the 13C NMR spectra did not immediately allow us to determine the number of 
carbons of compound 4, its preliminary analysis was able to point the signals at δC 126.8 
and δC 138.6 that could correspond to two olefinic carbons, the signal at δC 179.0 that 
might be related to one carboxyl carbon and the signal at δC 76.9 that could indicate one 
oxymethinic carbon, which was probably bonded to a hydroxyl group. A careful 
observation of the 13C NMR data suggested an ursane type skeleton, which could 
probably be the structure of ursolic acid. In order to verify this suggestion, the 13C NMR 
data of compound 4 were compared to the 13C NMR data for ursolic acid published by 
Moghaddam and co-workers (table 12). 
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Table 12 – 
13
C NMR data of compound 4 and 
13
C NMR data described in the literature 
Carbons 
Compound 4  
Moghaddam et al., 
2007 
Carbons 
Compound 4  
Moghaddam et al., 
2007 
δC  
(DMSO-d6 75 MHz) 
δC  
(DMSO-d6 125 MHz) 
δC  
(DMSO-d6 75 MHz) 
δC  
(DMSO-d6 125 MHz) 
C-1 38.4 39.2 C-16 25.9 24.7 
C-2 26.4 27.8 C-17 46.7 47.7 
C-3 76.9 77.7 C-18 53.2 53.2 
C-4 38.1 39.2 C-19 40.0 39.4 
C-5 54.8 55.6 C-20 39.0 39.3 
C-6 18.1 18.9 C-21 30.7 31.1 
C-7 32.7 33.6 C-22 36.6 37.2 
C-8 41.0 40.0 C-23 28.2 29.1 
C-9 46.9 47.9 C-24 15.1 16.1 
C-10 37.3 37.4 C-25 16.0 16.9 
C-11 23.9 23.7 C-26 16.3 17.8 
C-12 126.8 125.4 C-27 25.1 24.1 
C-13 138.4 139.0 C-28 179.0 179.1 
C-14 41.4 42.5 C-29 16.6 17.9 
C-15 28.1 28.4 C-30 23.1 21.9 
However, it would be necessary to repeat the NMR analysis because the signals of 
DMSO probably overlapped to some of the signals of the compound, hindering a more 
precise analysis. Although the melting point (287-288ºC) was coincident with ursolic acid 
on literature [Moghaddam et al., 2007], it is also necessary to determine the optical 
rotation of compound 4 because this parameter is a criterion of identity and purity. 
Nevertheless, it is interesting to note that ursolic acid result from the oxidation of uvaol at 
C-28. Both compounds have been widely isolated from the aerial part of plants as well as 
their precursor α-amyrin. The biosynthesis of these nonsteroidal triterpenes with ursane 
type skeleton is mediated by Cyt P450 monooxigenases as represented in the scheme of 
the figure 21 [Fukushima et al., 2011]. 
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Figure 21 – Pathway for the biosynthesis of ursolic acid 
In the last decade, it has been discussed the role of these triterpenoids in plant, which 
seems to be related to defense and development [Fukushima et al., 2011]. Indeed, these 
features could explain the observed biological activities that will be discussed later. 
Ursolic acid was already described in the specie C. catarinensis [Machado et al., 2008]. 
4.1.5. Structure elucidation of compound 5  
Compound 5 was isolated as white solid (149 mg). Actually, compound 5 is a mixture and 
this feature could be observed by TLC analysis because two different spots (Rf = 0.48 and 
Rf = 0.52; eluent: dichloromethane + acetone - 9:1) appeared after chemical development. 
The reason why we kept this mixture in this discussion is related with the biological activity 
that was observed. 
The 13C NMR data indicated that compound 5 was a mixture that could contain ursolic 
acid as the major compound and another triterpene maybe with similar skeleton, because 
the signals at δC 126.8 and δC 138.6 of the two olefinic carbons were doubled (δC 124.6 
and δC 138.2) and the carboxyl carbon signal at δC 179.0 was also doubled (δC 178.3). 
Since the two compounds have different retention factors, we will proceed to its 
separation by preparative TLC. 
4.2. Biological studies 
4.2.1. Evaluation of the antimicrobial activities 
The crude methanolic extract CME and the semi-purified fractions (CME1 and CME2) 
were evaluated for their antimicrobial activity by determining their MIC (minimum inhibitory 
concentration) and MLC (minimum lethal concentration) in some bacteria and fungi, as 
showed in the table 13. 
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Table 13 – Antimicrobial activities of CME, CME1 and CME2 expressed as MIC and (MLC) in 
μg/mL 
Microorganisms 
Extracts/controls*  
CME CME1 CME2 Gentamicin* Fluconazole* Amphotericin B* 
Staphylococcus 
aureus 
ATCC 25923 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
0.5 
(0.5) 
NT NT 
MRSA 
Clinical strain 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
640  
(640) 
NT NT 
Escherichia coli 
ATCC 25922  
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
0.5 – 1 
(1) 
NT NT 
Pseudomonas 
aeruginosa  
ATCC 27853 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
2 – 4 
(4) 
NT NT 
Candida albicans  
ATCC 10231 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
NT 
1  
(> 128) 
NT 
Aspergillus 
 fumigatus  
ATCC 46645 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
NT NT 
2 
(4) 
Trichophyton 
rubrum  
Clinical strains FF5 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
NT 
16 – 32 
(32 – 64) 
Not tested 
NT: Not tested. 
These results did not revealed which extract was more active or a possible candidate for 
further chemical investigation in order to find active compounds. Indeed, all the extracts 
presented MIC and MLC values greater than 256 μg/mL for both bacteria and fungi. 
Anyway, all the isolated compounds were also tested for their antibacterial and antifungal 
activities as demonstrated in the table 14. 
Table 14 – Antimicrobial activities of the isolated compounds expressed as MIC and (MLC) 
in μg/mL 
Microorganisms 
Compounds  
Compound 1  
(β-sitostenone) 
Compound 3  
(Uvaol) 
Compound 4 
(Ursolic acid) 
Compound 5 
(Mixture) 
Candida albicans  
ATCC 10231 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
Aspergillus 
 fumigatus  
ATCC 46645 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
Trichophyton 
rubrum 
Clinical strain FF5 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
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Table 14 (continued) – Antimicrobial activities of the isolated compounds expressed as MIC 
and (MLC) in μg/mL 
Microorganisms 
Compounds  
Compound 1  
(β-sitostenone) 
Compound 3  
(Uvaol) 
Compound 4 
(Ursolic acid) 
Compound 5 
(Mixture) 
Staphylococcus 
aureus 
ATCC 25923 
> 256  
(> 256) 
> 256  
(> 256) 
64 
(128-256) 
32 
(128) 
MRSA 
Clinical strain 
> 256  
(> 256) 
> 256  
(> 256) 
32-64 
(≥ 256) 
16 
(64-128) 
Enterococcus 
faecalis 
ATCC 29212 
NT NT 
32* 
(64-128)* 
≤ 16* 
(64-128)* 
Bacillus cereus 
NCTC 7587 
NT NT 
32* 
(64-128)* 
≤ 16* 
(32-64)* 
Escherichia coli 
ATCC 25922  
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
Pseudomonas 
aeruginosa  
ATCC 27853 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
> 256  
(> 256) 
NT: Not tested; * Preliminary results. 
Between the isolated compounds, only compound 4 (ursolic acid) and compound 5 (the 
mixture that probably contains ursolic acid) were active against the Gram-positive bacteria 
tested. Indeed, the decision of testing the bacteria E. faecalis and B. cereus was taken in 
order to confirm the selective activity of ursolic acid towards Gram-positive bacteria. This 
selectivity of ursolic acid to Gram-positive bacteria was also verified in the data collected 
from literature that are presented in the table 15. However, it is important to note the study 
of Fontanay and colleagues, since ursolic acid was inactive against MRSA (mecA gene), 
which is not in accordance with our results.  
The study of Fontanay et al. was performed using the protocol M7-A6, that is the previous 
version of the protocol used in our study, but the protocols have not significant differences 
in the microdilution methodology. Nevertheless, the inoculum size obtained by Fontanay 
and colleagues was 5 to 50 higher than our inoculum size, which may justify the 
differences between the results. 
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Table 15 – In vitro activities of ursolic acid in bacteria obtained from literature 
Bacterial strains or clinical 
isolates 
Antibacterial activity 
References 
Expressed as Values Unities 
Dermatophilus congolensis  MIC 15.0 μg/mL Gbaguidi et al., 2005 
Enterococcus faecium FN-1 
Enterococcus faecium BM4147 
MIC 
4.0 
4.0 
μg/mL 
Horiuchi et al., 2007 
Enterococcus faecalis NCTC 12201 
Enterococcus faecalis FA2-2 
MIC 
4.0 
4.0 
μg/mL 
Streptococcus pneumoniae R6 MIC 8.0 μg/mL 
Staphylococcus aureus OM481 
Staphylococcus aureus OM584 
MIC 
8.0 
8.0 
μg/mL 
Escherichia coli K12 MIC > 128 μg/mL 
Pseudomonas aeruginosa PAO1 MIC > 128 μg/mL 
Serratia marcescens NUSM8905 MIC > 128 μg/mL 
Enterococcus faecalis ATCC 29212 MIC 4.0 mg/L 
Fontanay et al., 2008 
Enterococcus faecalis (vanA gene) MIC 256.0 mg/L 
Enterococcus faecium (vanB gene) MIC 256.0 mg/L 
Staphylococcus aureus ATCC 25923 MIC 8.0 mg/L 
Staphylococcus aureus ATCC 29213 MIC 8.0 mg/L 
MRSA (mecA gene) MIC > 256 mg/L 
Pseudomonas aeruginosa ATCC 
27853 
MIC 256.0 mg/L 
Pseudomonas aeruginosa 
(overexpression of efflux pumps) 
MIC > 256 mg/L 
Escherichia coli ATCC 25922 MIC > 256 mg/L 
Penicillinase-producing Escherichia 
coli 
MIC > 256 mg/L 
Staphylococcus aureus ATCC 25923 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
 
10.5 
9.5 
8.5 
7.5 
mm 
(diameter) 
Wong et al., 2012 
Bacillus subtilis NCTC 8236 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
 
10.5 
9.5 
9.0 
8.0 
mm 
(diameter) 
Bacillus cereus ATCC 10876 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
 
7.0 
7.0 
7.0 
7.0 
mm 
(diameter) 
Escherichia coli ATCC 25922 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
No activity 
mm 
(diameter) 
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Table 15 (continued) – In vitro activities of ursolic acid in bacteria obtained from literature 
Bacterial strains or clinical 
isolates 
Antibacterial activity 
References 
Expressed as Values Unities 
Pseudomonas aeruginosa ATCC 
17853 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
No activity 
mm 
(diameter) 
Wong et al., 2012 Salmonella typhi (lab. strain) 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
 
11.0 
10.0 
10.0 
9.5 
mm 
(diameter) 
Klebsiella pneumoniae (lab. strain) 
Zone inhibition  
at 2 mg/mL 
at 1 mg/mL 
at 0.5 mg/mL 
at 0.25 mg/mL 
No activity 
mm 
(diameter) 
Regarding the study of Wong and co-workers, it was found that the compound was active 
towards the gram negative bacteria S. typhi, which indicate that ursolic acid seems to be 
selective to Gram-positive bacteria but it can also be active towards some Gram-negative 
bacteria. 
Furthermore, the mechanism of action of ursolic acid was already proposed by Kurek and 
colleagues because the compound inhibits the growth and survival of many bacteria, 
particularly Gram-positive bacteria. The effect of ursolic acid was tested on the Gram-
positive bacteria Listeria monocytogenes, demonstrating that the compound affected cell 
morphology and enhanced cell autolysis by inhibiting peptidoglycan turnover and affecting 
the mucopeptide profile of bacterial wall [Kurek et al., 2010].  
The table 16 compiles the results on the antifungal activity of ursolic acid. Our results 
were consistent with the results of Liu and colleagues but not conform to the Shai´s 
results. The reason for these differences is the method employed for MIC determination. 
Indeed, Liu and colleagues used the same standard method like us, while Shai et al. used 
a non-standardized method which makes difficult to compare the results. 
  
  
 Cecropia catarinensis Cuatrecasas (Urticaceae): Chemical and biological studies 
 
- 65 - 
 
Table 16 – In vitro activities of ursolic acid in fungi obtained from literature 
Fungal strains or clinical isolates 
Antifungal activity 
References 
Expressed as Values Unities 
Sporothrix schenckii MIC 32.0 μg/mL 
Shai et al., 2008 
Microsporum canis MIC 12.0 μg/mL 
Aspergillus fumigatus MIC 24.0 μg/mL 
Candida albicans ATCC 10231 MIC 63.0 μg/mL 
Cryptococcus neoformans MIC 63.0 μg/mL 
Candida guilliermondi MIC 15.6 μg/mL 
Candida spicata MIC 63.0 μg/mL 
Candida albicans ATCC 90028 MIC > 200 μg/mL 
Liu et al., 2009 Candida parapsilosis ATCC 22019 MIC > 200 μg/mL 
Candida krusei ATCC 6258 MIC > 200 μg/mL 
The mixture with ursolic acid was slightly more active than ursolic acid itself, which may 
suggest that the other compound is more active than ursolic acid or the mixture of both 
compounds may enhance the activity of each compound through a synergistic effect.  
It is important to mention that there were solubility issues with uvaol and β-sitostenone 
because the samples gelled in contact with the culture medium. These solubility issues 
may also justify the results obtained with uvaol. In fact, the published studies that 
evaluated the antibacterial effects of uvaol have also been indicating that the compound 
does not possess antibacterial activity. The table 17 compiles the data obtained from 
those studies. However, this solubility issue might be overcome using, for example, 
nanotechnology in order to increase its solubility in media with higher polarity. 
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Table 17 – In vitro activities of uvaol in bacteria obtained from literature 
Bacterial strains or clinical isolates 
Antibacterial activity 
References 
Expressed as Values Unities 
Enterococcus faecium FN-1 
Enterococcus faecium BM4147 
MIC 
> 128 
> 128 
μg/mL 
Horiuchi et al., 
2007 
Enterococcus faecalis NCTC 12201 
Enterococcus faecalis FA2-2 
MIC 
> 128 
> 128 
μg/mL 
Streptococcus pneumoniae R6 MIC 
> 128 
> 128 
μg/mL 
Staphylococcus aureus OM481 
Staphylococcus aureus OM584 
MIC 
> 128 
> 128 
μg/mL 
Escherichia coli K12 MIC > 128 μg/mL 
Pseudomonas aeruginosa PAO1 MIC > 128 μg/mL 
Serratia marcescens NUSM8905 MIC > 128 μg/mL 
Escherichia coli AG100 
Escherichia coli AG100TET8 
MIC 
> 200 
> 200 
g/L 
Martins et al., 
2011 
Salmonella enterica serotype Enteritidis 104 
Salmonella enterica serotype Enteritidis 104CIP 
Salmonella enterica serotype Enteritidis 5408 
Salmonella enterica serotype Enteritidis 5408CIP 
MIC 
> 200 
> 200 
> 200 
> 200 
g/L 
Enterococcus faecalis ATCC 29212 MIC 200 g/L 
Staphylococcus aureus ATCC 25923  
MRSA clinical strain 
MRSA COL 
MRSA COLOXA 
Staphylococcus aureus HPV 107 
MIC 
> 200 
> 200 
200 
100 
200 
g/L 
Mycobacterium tuberculosis H37Rv MIC > 200 g/L 
No data was found in the literature regarding the antimicrobial activities of β-sitostenone. 
However, any approach that improves its solubility in conventional culture media might 
also provide more conclusive results.  
4.2.2. The in vitro growth inhibitory evaluation on human cancer cell lines 
The plant extracts CME, CME1 and CME2 were tested for the in vitro inhibitory activity in 
the following three human tumour cell lines: breast adenocarcinoma (MCF-7), non-small 
cell lung cancer (NCI-H460) and melanoma (A375-C5). The results of the extracts 
inhibitory activity are presented in the table 18. 
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Table 18 – Growth inhibitory effects of CME, CME1 and CME2 in MCF-7, NCI-H460 and A375-
C5 cell lines 
Extracts/control* 
Growth inhibitory activity expressed in GI50  
MCF-7 cells NCI-H460 cells A375-C5 cells 
CME 58.8 ± 9.1 μg/mL 68.3 ± 7.2 μg/mL 80.2 ± 4.9 μg/mL 
CME1 31.8 ± 6.7 μg/mL 36.1 ± 9.8 μg/mL 42.1 ± 8.8 μg/mL 
CME2 80.9 ± 19.2 μg/mL 85.4 ± 27.2 μg/mL ≥200 μg/mL 
Doxorubicin* 60.3 ± 1.2 µM 19.6 ±1.9 µM 130.0 ± 25.2 µM 
The results are expressed as GI50 (μg/mL) values of the tested extracts using MCF-7, 
NCI-H460 and A375-C5 cell lines by means ± SD of at least three independent 
experiments performed in duplicate. Doxorubicin was used as a positive control. 
Our results showed that the crude extract CME inhibited the growth of the three tumour 
cell lines. In turn, the less polar fraction CME1 was not only active against the three 
tumour cell lines used in the assay, but also it presented the highest growth inhibitory 
activities for the three cell lines between the three samples. CME2 showed the lowest 
inhibitory activities for breast and lung cancer cell lines, being inactive for melanoma cells. 
These results suggested that the more active compounds could be in the less polar 
fraction CME1 or this fraction could be more concentrated in active compounds. Indeed, 
the comparative analytical TLC of the three samples showed that there were two violet/red 
spots in the plate after development with H2SO4. These spots (Rf. 0.76 and 0.73; eluent: 
CH2Cl2 + acetone 9:1) were more pronounced in the less polar fraction CME1.  
In accordance to this bioassay-guided evaluation, CME1 was selected for further 
purification procedures in order to isolate and identify the compounds that might be 
responsible for the activity of CME1. However, for different reasons, none of the isolated 
compounds were tested against the selected panel of cancer cell lines. Firstly, ursolic acid 
has been widely isolated and identified within the plant kingdom and it has also been 
extensively tested for its in vitro activity in cancer cell lines (table 19). Secondly, as uvaol 
and β-sitostenone presented that unexpected solubility issues during the antimicrobial 
tests, the same problems would be expected to occur in the in vitro growth inhibitory 
evaluation tests.  
  
  
 Cecropia catarinensis Cuatrecasas (Urticaceae): Chemical and biological studies 
 
- 68 - 
 
Table 19 – In vitro activities of ursolic acid in cancer cell lines obtained from literature 
Cell lines 
Cytotoxic activity 
References 
Expressed as Values Unities 
HL-60 (human promyelocytic leukaemia 
cells) 
IC50 14.63 μM 
Cheng et al., 
2013 
SMMC-7721 (human liver hepatocarcinoma 
cells) 
IC50 19.78 μM 
A-549 (human lung carcinoma cells) IC50 20.29 μM 
MCF-7 (human breast carcinoma cells) IC50 > 40 μM 
SW-480 (human colon adenocarcinoma 
cells) 
IC50 21.36 μM 
MGC-803 (human gastric cancer cells) 
Inhibition rate  
at 20 μM 
51.70 ± 5.60 % 
Liu et al., 2012 
Bcap-37 (human breast cancer cells) 
Inhibition rate  
at 20 μM 
48.40 ± 5.90 % 
MCF-7 (human breast carcinoma cells) 
Inhibition rate  
at 20 μM 
49.40 ± 4.10 % 
PC3 (human prostate cancer cells) 
Inhibition rate  
at 20 μM 
57.70 ±1.90 % 
NIH3T3 (murine embryo fibroblast cells) 
Inhibition rate  
at 20 μM 
21.70 ± 4.90 % 
HepG2 (human hepatoma cells) IC50 68.82 ± 3.71 μM 
Shao et al., 
2011 
BGC-823 (human gastric cancer cells) IC50 66.38 ± 0.66 μM 
SH-SY5Y (human bone marrow 
neuroblastoma cells) 
IC50 54.62 ± 3.87 μM 
HeLa (human cervical adenocarcinoma 
cells) 
IC50 33.12 ± 0.63 μM 
HT-29 (human colon adenocarcinoma cells) IC50 26.31 ± 2.74 μM 
Bai et al., 2011 
HEp-2 (human larynx carcinoma cells ) IC50 53.42 ± 4.07 μM 
BGC-823 (human gastric cancer cells) IC50 22.96 ± 0.99 μM 
GES-1 (human gastric epithelial 
immortalized cells) 
IC50 93.83 ± 8.51 μM 
HL-60 (human promyelocytic leukaemia 
cells) 
Inhibition rate  
at 10 μM  
7.57 % 
Wang et al., 
2010 
BGC-823 (human gastric cancer cells) 
Inhibition rate  
at 10 μM  
12.49 % 
HEp-2 (human larynx carcinoma cells ) Inhibition rate  
at 10 μM  
10.77 % 
HeLa (human cervical adenocarcinoma 
cells) 
Inhibition rate  
at 10 μM  
12.36 ± 3.01 % 
Meng et al., 
2009 
SK-OV-3 (human ovarian carcinoma cells) 
Inhibition rate  
at 10 μM  
9.06 ± 2.02 % 
BGC-823 (human gastric cancer cells) 
Inhibition rate  
at 10 μM  
10.20 ± 1.02 % 
HeLa (human cervical adenocarcinoma 
cells) 
IC50 > 10 μM 
SK-OV-3 (human ovary adenocarcinoma 
cells) 
IC50 > 10 μM 
BGC-823 (human gastric cancer cells) IC50 > 10 μM 
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Table 19 (continued) – In vitro activities of ursolic acid in cancer cell lines obtained from 
literature 
Cell lines 
Cytotoxic activity 
References 
Expressed as Values Unities 
Ca9-22 (human gingival carcinoma cells) IC50 5.90 μg/mL 
Chen et al., 
2009 HL-60 (human promyelocytic leukaemia 
cells) 
IC50 8.70 μg/mL 
A-549 (human lung carcinoma cells) EC50 3.71 μM 
Lee et al., 2008 
SK-OV-3 (human ovary adenocarcinoma 
cells) 
EC50 3.65 μM 
SK-MEL-2 (human skin melanoma cells) EC50 3.62 μM 
HCT-15 (human epithelial colorectal 
adenocarcinoma cells) 
EC50 5.44 μM 
P-388 (murine leukaemia cells) IC50 3.50 μg/mL 
Chinou et al., 
2007 NSCLC-N6 (human bronchial epidermoid 
cancer cells) 
IC50 9.00 μg/mL 
KB (human cervical carcinoma cells) EC50 8.30 μM 
Tatsuzaki et al., 
2007 KB-VIN (multi-drug resistant KB sub-line 
expressing P-glycoprotein) 
EC50 8.10 μM 
HepG2 (human hepatoma cells) IC50 18.00 μM 
Tian et al., 2006 
R-HepG2 (drug-resistance strain of HepG2 
cells) 
IC50 15.00 μM 
HL-60 (human promyelocytic leukaemia 
cells) 
EC50 72.00 μg/mL 
Ma et al., 2005 
BGC-823 (human gastric cancer cells) EC50 53.70 μg/mL 
Bel-7402 (human hepatocellular carcinoma 
cells) 
EC50 45.00 μg/mL 
HeLa (human cervical adenocarcinoma 
cells) 
EC50 49.40 μg/mL 
A2780 (human ovarian cancer cells) IC50 8.00 μg/mL Cao et al., 2004 
Some of the studies presented in the table 19 were related to the chemical synthesis of 
ursolic acid derivatives in order to study the structure-activity relationship of the lead 
compound and its synthesized derivatives [Bai et al., 2011; Shao et al., 2011; Wang et al., 
2010; Meng et al., 2009; Tatsuzaki et al., 2007; Ma et al., 2005]. However, there are also 
reports on the mechanism of action of ursolic acid: the compound showed antiangiogenic 
properties and inhibited tumour cell invasion and metastasis, which seemed to be related 
to its ability to inhibit DNA replication [Resende et al., 2006; Tian et al., 2006]; the 
compound also induced apoptosis through the activation of caspases and the release of 
intracellular Ca2+ and cytochrome C [Messner et al., 2011; Resende et al., 2006; Tian et 
al., 2006]; ursolic acid inhibited human topoisomerase I and topoisomerase IIα by 
competing with DNA for the same binding sites on the enzymes, the compound did not 
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intercalate with DNA and did not bind to the DNA minor grove as topoisomerase poisons 
do, therefore, the compound seemed to be a dual catalytic inhibitor of topoisomerase I 
and topoisomerase IIα, which prevented the interaction between the enzymes and DNA 
[Syrovets et al., 2000].  
It was found only one study with the in vitro effects of β-sitostenone against a panel of 
cancer cells and the results are presented in the table 20. Nonetheless, the antitumour 
promoting activity of β-sitostenone was determined using EBV-EA assay in Raji cell line, 
thus 20 μg/mL of β-sitostenone inhibited 97.93% ± 1.5% of cell viability and the inhibition 
rate was 78.4% ± 1.5% [Habsah et al., 2005].  
Table 20 – In vitro activities of β-sitostenone in cancer cell lines obtained from literature 
Cell lines 
Cytotoxic activity 
References 
Expressed as Values Unities 
HCT-8 (human colorectal adenocarcinoma cell) IC50 60.60 μM 
Gallo et al., 
2010 
MDA-MB-435 (human breast carcinoma cells) IC50 60.60 μM 
SF-295 (human glioblastoma multiforme cells) IC50 60.60 μM 
HL-60 (human acute myelocytic leukemia cells) IC50 60.60 μM 
The inhibition of EBV-EA activation was also assayed for uvaol, again using Raji cells, 
which was determined at four different concentrations (1000, 500, 100 and 10 mol ratio) of 
uvaol. The compound showed an inhibitory effect at 100 mol ratio and exhibited significant 
activity at the highest concentration, indicating that possess antitumor promoting effects 
[Ukiya et al., 2002]. Concerning its cytotoxic effects, uvaol was tested against human 
1321N1 astrocytoma cell line, as astrocytomas are an aggressive type of primary 
malignant tumours in the neurological system. The compound affected cell proliferation 
and induced cell death, modulating the apoptotic response that was characterised by 
nuclear condensation and fragmentation, ROS production and loss of mitochondrial 
transmembrane potential [Martín et al., 2009].  
Furthermore, the effects of uvaol on parental L5178 cells (mouse lymphoma cells) and 
MDR1-transfectes L5178 cells (mouse lymphoma cells containing the human efflux pump 
gene MDR1) were obtained by Martins and colleagues. The results are presented in the 
table 21. Additionally, the group found that uvaol was effective in inhibiting the extrusion of 
rhodamine 123 and ethidium bromide from the MDR1-transfectes L5178 cells because 
these two P-gp substrates were intracellularly accumulated, which indicated that uvaol 
may be a promising compound for the reversal of multidrug resistance [Martins et al., 
2010]. 
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Table 21 – In vitro activities of uvaol in cancer cell lines obtained from literature 
Cell lines 
Cytotoxic activity 
References 
Expressed as Values Unities 
Parental L5178 cells IC50 7 mg/L 
Martins et al., 
2010 
MDR1-transfectes L5178 cells IC50 13 mg/L 
Moreover, uvaol inhibited significantly cell growth and proliferation of MCF-7 breast cancer 
cell line in a dose and time-dependent manner. The compound showed a significant 
antiproliferative effect at 100 μM, which involved cell cycle arrest. Although the compound 
did not show free radical scavenging activity, the compound protected against oxidative 
DNA damage at 10 μM, reducing intracellular ROS level and preventing H2O2-induced 
oxidative injury [Allouche et al., 2011]. 
According to the data presented in this section, it is possible that the growth inhibitory 
activity of CME1 may be justified by its chemical composition on pentacyclic triterpenes, 
since ursolic acid and uvaol are known to possess that activity. However, the groups with 
higher polarity remain to be studied, which may be a source of active compounds and with 
remarkable chemical structures. 
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Chapter 5 
Conclusions 
 
 
 
 
 
 
  
  
  
   
 
 
 
 
 
 
Cecropia catarinensis: http://www.ufrgs.br/fitoecologia/florars/open_sp.php?img=906; 
http://www.ufrgs.br/fitoecologia/florars/open_sp.php?img=570; 
http://www.ufrgs.br/fitoecologia/florars/open_sp.php?img=8180; 
http://www.ufrgs.br/fitoecologia/florars/open_sp.php?img=904. 
  
Cecropia catarinensis 
  
 Cecropia catarinensis Cuatrecasas (Urticaceae): Chemical and biological studies 
 
- 73 - 
 
5. Conclusions 
Plants that belong to the genus Cecropia have been used in traditional medicine for the 
treatment of hypertension, Diabetes Mellitus or asthma. The cardiovascular effects have 
been attributed to the flavonoid content of their aqueous extracts, while their 
hypoglycaemic effects have been correlated with their content in chlorogenic acid.  
The genus Cecropia is still poorly investigated in the anticancer drug development field. 
Indeed, only C. lyratiloba and C. pachystachya were evaluated in preclinical studies, 
which means that C. catarinensis was tested for the in vitro growth inhibitory effects of 
cancer cell lines for the first time. Our results demonstrated that the crude methanolic 
extract (CME) and the semipurified fraction with the lowest polarity (CME1) were active 
against the panel of cancer cell lines tested (MCF-7, NCI-H460 and A375-C5 cells). 
However, CME1 was more active than CME towards the three cell lines, which indicated 
that CME1 was probably more concentrated in active compounds. 
CME1 was selected for further chemical investigation and purification, affording four 
compounds. The structures of those compounds were elucidated by spectroscopic and 
spectrometric methods (NMR and/or MS) and were compared with the data obtained from 
literature. It is still necessary to proceed to the determination of optical rotation because 
this parameter is an important criterion of identity and purity. Two known pentacyclic 
triterpenoids with ursane type skeleton (uvaol and ursolic acid) were indicated as the 
structures of two of the isolated secondary metabolites, which could explain the cytotoxic 
activity of CME1. Two known steroids (β-sitostenone and β-sitosterol) were also indicated 
as the structures of the other two secondary metabolites that were isolated from CME1. 
The antimicrobial effects of extracts obtained from C. peltata were described in one study 
and the results corroborated with the plant use for the treatment of infections in Colombian 
folk medicine. Despite having been evaluated for the first time, our extracts of C. 
catarinensis were inactive towards the microorganisms tested. However, among the 
isolated secondary metabolites, the compound that has been suggested as ursolic acid 
demonstrated to be active and selective for gram-positive bacteria. 
For publication purposes, there are still some experiments to perform in order to confirm 
the structure suggestions of the already isolated secondary metabolites. Additionally, the 
mixture that seemed to be composed with ursolic acid should be re-purified and re-tested 
against the bacteria for which it was active. Furthermore, there are other groups that were 
obtained from the initial fractionation of CME1 that may be purified so that other 
secondary metabolites can be isolated.  
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This master also allowed the writing of two articles, one original article and one review, 
which are currently in the final stage of correction. The provisional title of the original 
article is “The in vitro cell growth inhibition of the crude extract of Cecropia catarinensis” 
and the provisional title of the review is “Soft corals: a potential contribution to enrich the 
clinical pipeline for anticancer drug discovery”. 
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Annex 1 
13C NMR data of the sample of β-sitosterol: 
Table 22 – 
13
C NMR data of the sample of β-sitosterol and 
13
C NMR data described in the 
literature 
Carbons 
Sample of β-
sitosterol 
Chaturvedula and 
Prakash, 2012 
Carbons 
Sample of β-
sitosterol 
Chaturvedula and 
Prakash, 2012 
δC (CDCl3 75 MHz) δC (CDCl3 150 MHz) δC (CDCl3 75 MHz) δC (CDCl3 150 MHz) 
C-1 37.2 37.5 C-16 28.2 28.5 
C-2 29.7 31.9 C-17 56.0 56.3 
C-3 71.8 72.0 C-18 36.1 36.3 
C-4 42.3 42.5 C-19 19.0 19.2 
C-5 140.7 140.9 C-20 33.9 34.2 
C-6 121.7 121.9 C-21 26.0 26.3 
C-7 31.8 32.1 C-22 45.8 46.1 
C-8 31.6 32.1 C-23 23.0 23.3 
C-9 50.1 50.3 C-24 12.0 12.2 
C-10 36.5 36.7 C-25 29.1 29.4 
C-11 21.1 21.3 C-26 19.8 20.1 
C-12 39.7 39.9 C-27 19.4 19.6 
C-13 42.3 42.6 C-28 18.8 19.0 
C-14 56.7 56.9 C-29 11.8 12.0 
C-15 26.0 26.3  
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